PASCAL GOLDSCHMIDT-CLERMONT, M.D., F.A.C.C., F.A.H.A.

CURRICULUM VITAE

DATE: 2022

PERSONAL 

NAME:  PASCAL J. GOLDSCHMIDT, M.D., F.A.C.C., F.A.H.A.

CURRENT JOBS: CHIEF MEDICAL OFFICER, LENNAR CORP. (NYSE: LEN)

ADDITIONAL ROLES:

Founder, President and CEO, ALZADY International LLC

Epiphany Bioscience, Inc. Co-Founder, Board of Directors Member

DemeRX LLC, Board of Directors Member, Chief Medical Officer

Neobiosis LLC, Chief Medical Officer

Retired, United HomeCare, Board of Directors, Miami, Florida

Retired, MEDNAX (NYSE: MD), Board of Directors

Retired, Health Management Associates, Board of Directors

Retired, OPKO, Board of Directors

Dean Emeritus, Professor of Medicine Emeritus, University of Miami Miller School of Medicine 

OFFICE PHONE:  (+1) 305 322-9402

OFFICE ADDRESS: 16800 SW 88 Court, Palmetto Bay, FL 33157

EMAIL Address: 

pgoldschmidt10@gmail.com

drpascal@lennar.com

pgoldschmidt@med.miami.edu

SPECIALTY:   Medicine, Cardiology

CITIZENSHIP:  US citizenship (born in Brussels, Belgium)

Naturalized August 27, 2002

HIGHER EDUCATION

INSTITUTIONAL:

October 1972 – September 1976 Université Libre de Bruxelles

Brussels, Belgium

Bachelor of Medical Sciences, magna cum laude

October 1976 – June 1980 Université Libre de Bruxelles.

Brussels, Belgium

M.D., summa cum laude, valedictorian, Fleurice Mercier Prize Laureate

NON-INSTITUTIONAL:

October 1980 – April 1983 Intern and Resident in Medicine

Erasme Academic Hospital

Universite Libre de Bruxelles

Brussels, Belgium

May 1983 – June 1986 Research Fellow

Department of Immunology and Microbiology

Medical University of South Carolina

Charleston, South Carolina

July 1986 – June 1988 Resident in Medicine

Union Memorial Hospital

Baltimore, Maryland

July 1988 – June 1991 Clinical Fellow in Cardiology 

Research Fellow in Cell Biology and Anatomy

Johns Hopkins University

Baltimore, Maryland

CERTIFICATION, LICENSURE

1984 Educational Commission for Foreign Medical Students (ECFMG)

1985 Federation Licensing Examination (FLEX) 

1986 – 1997 Maryland

1997 – 2000 Ohio

2000 – North Carolina

2004    Board ceriified in internal medicine #118032

2006 – Present Florida

EXPERIENCE 

ACADEMIC:

1991 - 1994 Assistant Professor, Department of Medicine, Cardiology Division

Department of Cell Biology and Anatomy

Johns Hopkins University School of Medicine, Baltimore, Maryland

1991 - 1997 Director, Bernard Vascular Biology Laboratory

Johns Hopkins University, Baltimore, Maryland

1991 – 1997 Co-Director Henry Ciccarone Center for the Prevention of Heart Disease

Johns Hopkins University, Baltimore, Maryland

1994 - 1997 Co-Director, Thrombosis Center

Johns Hopkins University, Baltimore, Maryland

1994 - 1997 Associate Professor, Department of Medicine, Cardiology Division

Department of Cell Biology and Anatomy

Johns Hopkins University School of Medicine, Baltimore, Maryland

1996 - 1997 Associate Professor, Department of Pathology

Johns Hopkins University School of Medicine, Baltimore, Maryland

1997 - 2000 Director, Heart and Lung Research Institute

The Ohio State University Medical Center, Columbus, Ohio

1998-2000 Director, Division of Cardiology

The Ohio State University Hospitals, Columbus, Ohio

1997 - 2000 Professor of Internal Medicine, Cell Biology and Genetics

College of Medicine and Public Health, Cardiology Division

The Ohio State University, Columbus, Ohio

1997 - 2000 John H. and Mildred C. Lumley Chair in Medicine

Department of Internal Medicine, College of Medicine and Public Health

The Ohio State University, Columbus, Ohio

2000 -2003 Chief of Cardiology, Department of Medicine

Duke University, Durham, North Carolina

2000 - 2006 Director, Duke Cardiovascular Center for Genomic Science

Duke University, Durham, North Carolina

2000 - 2006 Edward S. Orgain Professor of Cardiology, Professor of Medicine

Professor of Genetics, Professor of Cell Biology, Professor of Pathology Duke University Medical Center, Durham, North Carolina

2000 - Present Honorary Consulting Professor of Cardiology

Universite Libre de Bruxelles, Brussels, Belgium

2003 - 2006 Chairman, Department of Medicine

Duke University Medical Center, Durham, North Carolina

2006 - 2016 Senior Vice President for Medical Affairs and Dean

Tenured Professor of Medicine, Leonard M. Miller School of Medicine

University of Miami, Miami, Florida

2007 - 2016 Founder and Chief Executive Officer, UHealth

University of Miami Health System, Miami, Florida

2016 - 2017 Dean Emeritus

Director of Strategic International Projects

Tenured Professor of Medicine, Cardiology

University of Miami Miller School of Medicine and UHealth, Miami, Florida

2018 - Present Dean Emeritus, Professor of Medicine Emeritus, University of Miami

2020 - Present Chief Medical Officer Lennar Corporation

CLINICAL:  

1991 - 1997 Attending Physician, Coronary Care Unit

Johns Hopkins University, Baltimore, Maryland

1991 - 1997 Attending Physician, The Ciccarone Center for the Prevention of Heart Disease 

Johns Hopkins University, Baltimore, Maryland

1997 – 2000 Attending Physician, Coronary Care Unit and Outpatient Cardiology Clinics 

The Ohio State University Hospitals, Columbus, Ohio

2000 – 2006 Attending Physician, Coronary Care Unit and Outpatient Cardiology Clinics 

Duke University Medical Center, Durham, North Carolina

2006 – 2018 Attending Physician, Coronary Care Unit and Outpatient Cardiology Clinics 

University of Miami Hospital and Clinics

UHealth, University of Miami, Miami, Florida

2006-Present Attending Physician Jackson Memorial Hospital, Miami Florida

CONSULTING POSITIONS:  

1996 – 1998 Member, Scientific Advisory Board

Otsuka American Pharmaceutical, Inc., Palo Alto, California

1996 – 1998 Member, Scientific Advisory Board

CardioGenesis Corporation, Palo Alto, California

2001 – 2002 Member, Review Panel

Doris Duke Charitable Foundation, New York, New York

2001 – 2002 Vice-Chair Scientific Board

The Sarnoff Endowment for Cardiovascular Science, Great Falls, Virginia

2002 – 2003 Chair, Scientific Board

The Sarnoff Endowment for Cardiovascular Science, Great Falls, Virginia

2005 – 2006 Bristol-Myers Squibb

Merck, Imedd, Novartis, Sanofi, Eli Lilly

2003 – Present Synecor, Scientific Committee

2006 – Present Mednax, Board of Directors

2007 – 2011 OPKO, Board of Directors

2011 – 2013 Health Management Associates, Board of Director

2015 – 2017 Member, Walgreens – Health System Innovation Advisory Board

HONORS AND AWARDS

1980 Prix Fleurice Mercier (Valedictorian of Class of 225), Summa Cum Laude 

Universite Libre de Bruxelles

1983 NATO Scientific Award

1984 NATO Scientific Award

1984 Clinical Research Fellowship Award, Medical University of South Carolina

1985 Clinical Research Fellowship Award, Medical University of South Carolina

1985 Diplomate, Educational Commission for Foreign Medical Graduates Examination

1986 Diplomate, Federation Licensing Examination

1990 The Johns Hopkins University School of Medicine Basic Science Award for 

Postdoctoral Investigation, Johns Hopkins University

1990 American Heart Association Fellowship Award

1991 Katz Prize Finalist, American Heart Association Clinician Scientist Award 

Johns Hopkins University School of Medicine

1995 Syntex Scholars Program Award for Outstanding Achievement in Cardiovascular Research 

Established Investigator Award, American Heart Association

1996 Laureate, The Ohio State University Heart and Lung Institute Directorship Search

1997 John H. and Mildred C. Lumley Endowed Chair of Medicine, The Ohio State University

1997 Elected, American Society for Clinical Investigation

1999 Fellow, American College of Cardiology (FACC)

2002 Association of Black Cardiologists, Inc., Award for Commitment to Diversity and Cultural Enrichment in Medical Education 

2003 Elected, Association of American Physicians

2004 Society of Scholars, Johns Hopkins University

2006 Honorary Grand Marshall, Humane Society Walk

2007 Best Doctors in America Peer Recognition 

2008 The Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences, The Ohio State University

2010 Business Leader of the Year -- Hospital Category, Business Leader Media

2010 Outstanding Citizenship Award, Poder Magazine and the Americas Business Council (ABC) Foundation

2012 Super Doctors Peer Recognition (2012-2013)

2015 Claude Pepper Award – Education/Advocacy (2015 United HomeCare Annual Dinner)

2016 Hero award from the American Medical Women’s Association (AMWA) for longstanding commitment to creating career opportunities for women in medicine

2021 Claude Pepper Award – Education/Advocacy (2015 United HomeCare Annual Dinner)

PATENTS AWARDED

Patents by Inventor Pascal Goldschmidt-Clermont

Pascal Goldschmidt-Clermont has filed for patents to protect the following inventions. This listing includes patent applications that have already been granted by the United States Patent and Trademark Office (USPTO).

1. METHODS FOR THE NON-TOXIC TREATMENT FOR OPIOID DRUG WITHDRAWAL COMBINING NORIBOGAINE AND CANNABINOIDS

   Publication number: 20220265675

   Abstract: The present invention is directed to the treatment of chemical substance abuse and withdrawal symptoms, especially withdrawal symptoms associated with opioids, utilizing a combination of an effective amount of a cannabinoid, in particular, cannabidiol (CBD) and/or A9-tetrahydrocannabinol (THC) in combination with low dosage noribogaine or a derivative salt, solvate or ansolvate thereof to treat withdrawal symptoms, both acute and longer term.

   Type: Application

   Filed: July 13, 2020

   Publication date: August 25, 2022

   Inventors: Philip SIGEL, Deborah MASH, Pascal GOLDSCHMIDT

2. Lsamp gene associated with cardiovascular disease

   Publication number: 20110070583

   Abstract: The LSAMP gene can be used for cardiovascular disease risk assessment, in particular Left Main Disease. The genetic risk attributable to LSAMP adds to known cardiovascular disease risk factors. Assessment of risk attributable to LSAMP permits early initiation of preventive and therapeutic strategies. Given the pronounced clinical risk associated with Left Main Disease, such risk assessment should significantly reduce morbidity and mortality.

   Type: Application

   Filed: August 19, 2010

   Publication date: March 24, 2011

   Inventors: Jeffery M. Vance, Pascal Goldschmidt, Elizabeth Hauser, William Kraus, Margaret A. Pericak-Vance

3. Methods of Determining the Risk of Developing Coronary Artery Disease

   Publication number: 20090226420

   Abstract: The invention relates to predicting, or aiding in predicting, which individuals are at risk of developing coronary artery disease. The invention provides a method for identifying an individual who has an altered risk for developing CAD. The invention further relates to methods of reducing the likelihood that a subject will develop CAD. The invention further provides reagents, nucleic acids and kits comprising nucleic acids containing a polymorphism in a CAD-determinative gene.

   Type: Application

   Filed: November 10, 2006

   Publication date: September 10, 2009

   Inventors: Elizabeth Hauser, Pascal Goldschmidt, Simon Gregory, William Kraus, Jeffery Vance

4. Atherosclerosis

   Publication number: 20080095751

   Abstract: The present invention relates, in general, to atherosclerosis and, in particular, to a method of treating atherosclerosis and to cells suitable for use in such a method.

   Type: Application

   Filed: April 27, 2007

   Publication date: April 24, 2008

   Applicant: DUKE UNIVERSITY

   Inventors: Chunming Dong, Pascal Goldschmidt

5. Lsamp gene associated with cardiovascular disease

   Publication number: 20070148661

   Abstract: The LSAMP gene can be used for cardiovascular disease risk assessment, in particular Left Main Disease. The genetic risk attributable to LSAMP adds to known cardiovascular disease risk factors. Assessment of risk attributable to LSAMP permits early initiation of preventive and therapeutic strategies. Given the pronounced clinical risk associated with Left Main Disease, such risk assessment should significantly reduce morbidity and mortality.

   Type: Application

   Filed: July 18, 2006

   Publication date: June 28, 2007

   Applicant: Duke University

   Inventors: Jeffery Vance, Pascal Goldschmidt, Elizabeth Hauser, William Kraus, Margaret Pericak-Vance

6. Atherosclerotic phenotype determinative genes and methods for using the same

   Publication number: 20060141493

   Abstract: Genes whose expression is correlated with and determinant of an atherosclerotic phenotype are provided. Genes whose expression is correlated with and determinant of an atherosclerotic susceptibility are also provided. Also provided are methods of using the subject atherosclerotic determinant genes or the atherosclerotic susceptibility genes in diagnosis and treatment methods, as well as drug screening methods. In addition, reagents and kits thereof that find use in practicing the subject methods are provided. Also provided are methods of determining whether a gene is correlated with a disease phenotype, where correlation is determined using at least one parameter that is not expression level and is preferably determined using a binary prediction tree analysis.

   Type: Application

   Filed: August 4, 2005

   Publication date: June 29, 2006

   Applicant: Duke University Office of Science and Technology

   Inventors: Mike West, Joseph Nevins, Pascal Goldschmidt, David Seo

7. Methods and compositions for correlating genetic markers with cardiovascular disease

   Publication number: 20060115845

   Abstract: The present invention provides methods of identifying a subject having an increased or decreased risk of developing cardiovascular disease, comprising: a) correlating the presence of one or more genetic markers in chromosome 3q13.31 with an increased or decreased risk of developing cardiovascular disease; and b) detecting the one or more genetic markers of step (a) in the subject, thereby identifying the subject as having an increased or decreased risk of developing cardiovascular disease. Also provided are methods of identifying subjects with cardiovascular disease as having a good or poor prognosis, as well as methods of identifying effective treatment regimens for cardiovascular disease, based on correlation with genetic markers in chromosome 3q13.31.

   Type: Application

   Filed: October 27, 2005

   Publication date: June 1, 2006

   Inventors: Jeffery Vance, Pascal Goldschmidt, Simon Gregory, William Kraus

8. Atherosclerotic phenotype determinative genes and methods for using the same

   Publication number: 20030224383

   Abstract: Genes whose expression is correlated with and determinant of an atherosclerotic phenotype are provided. Also provided are methods of using the subject atherosclerotic determinant genes in diagnosis and treatment methods, as well as drug screening methods. In addition, reagents and kits thereof that find use in practicing the subject methods are provided. Also provided are methods of determining whether a gene is correlated with a disease phenotype, where correlation is determined using at least one parameter that is not expression level and is preferably determined using a Bayesian analysis.

   Type: Application

   Filed: November 12, 2002

   Publication date: December 4, 2003

   Inventors: Mike West, Joseph R. Nevins, Pascal Goldschmidt

PUBLICATIONS

BOOKS:

1. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, Nel AE, Lee WM, Evidence of circulating Gc: actin complexes in health and disease, In: Vitamin D; Chemical, Biochemical and Clinical Update, AW Norman, K Schaefer, HG Grigoleit and DV Herrath, eds., Walter De Gruyter & Co., 1103-1104, 1985.

2. Nel AE, Petrini M, Emerson DL, Goldschmidt-Clermont PJ, Galbraith RM, Altered configuration of D-binding protein (Gc) on membranes of abnormal and malignant B lymphocytes, In: Vitamin D; Chemical, Biochemical, and Clinical Update, AW Norman, K Schaefer, HG Grigoleit and DV Herrath, eds., Walter De Gruyter & Co., 691-692, 1985.

3. Goldschmidt-Clermont PJ, Arnaud P, Galbraith RM, Interaction of Gc (Vitamin D-binding protein) with G-actin or proteolytic fragments of actin causes similar alteration in IEF profile, In: Protides of the biological fluids, H. Peeters, ed., Pergamon Press, New York, 899-901, 1986.

4. Pollard TD, Magnus A, Doberstein SK, Goldschmidt-Clermont PJ, Kaiser DA, Machesky LM, Maciver S, Rimm DL, Wachsstock D, Structure-function studies of the actin filament system of Acanthamoeba, In: Springer Series in Biophysics, Cytoskeletal and Extracellular Proteins, U. Aebi and J. Engel, eds., 271-279, 1989.

5. Goldschmidt-Clermont PJ, Myocardial infarction: coronary artery thrombosis or spasm, In: The Johns Hopkins Medical Grand Rounds, PA Murphy and JJ Harden eds., Vol. XIX, 17-24, 1993.

6. Goldschmidt-Clermont PJ, Vitamin D Binding/Gc protein, In: Guidebook to the Cytoskeletal and Motor Proteins, R.D. Vale and T. Kreis, eds., Oxford University Press, 92-94, 1993.

7. Heldman AW and Goldschmidt-Clermont PJ, Cell signaling and motile response, In: Cell Behaviour Adhesion and Motility, GE Jones, C. Wigley, RM Warn, Society for Experimental Biology, eds., Portland Press, 317-324, 1993.

8. Crawford LE, Tucker RW, Goldschmidt-Clermont PJ, Actin Regulation and Surface Catalysis, In: Actin: Biophysics, Biochemistry and Cell Biology, JE Estes and PJ Higgins, eds., Kluwer Academic Publishers Group,105-112, 1994.

9. Heldman AW, Furman MI, Goldschmidt-Clermont PJ, Coronary Artery Disease and Atherogenesis, In: Molecular Basis of Medicine, CV Dang and AM Feldman, eds., Mosby-Year Book, Inc., 1995.

10. Blumenthal RS, Calkins H, Goldschmidt-Clermont PJ, Prevention of Sudden Cardiac Death, In: Cardiac Arrest. The Science and Practice of Resuscitation Medicine, NA Paradis, HR Halperin and RM Novak, eds., Williams and Wilkins, 353-369, 1995.

11. Kandzari DE, Chen J, Goldschmidt-Clermont PJ, Regulation of the actin cytoskeleton by inositol phospholipid pathways, In: Subcellular Biochemistry (vol. 26): myo-Inositol Phosphates, Phosphoinositides and Signal Transduction, BB Biswas and S Biswas, eds., Plenum Press, 1996.

12. Moldovan L and Goldschmidt-Clermont PJ, Of Proteins, Redox States and Living Things, In: Dynamical Networks in Physics and Biology, 1999.

13. Hassanain H and Goldschmidt-Clermont PJ, Rac, Superoxide, and Signal Transduction, In: Antioxidant and Redox Regulation of Genes, C. Sen ed., Academic Press, 47-79, 1999.

14. Marsh CB, Kelley TW, Graham MM, Dong C, Goldschmidt-Clermont PJ, Monocytes may regulate tissue fibrosis: Role of reactive oxygen species in monocyte survival and in the activation of latent transforming growth factor-β, In: Chest, 120 (SUPPL.), 15S-16S, 2001.

15. Goldschmidt-Clermont PJ, Lopes N, Crawford LE, Atherosclerosis and Coronary Artery Disease, In: Platelets, A. Michelson ed., Academic Press/Elsevier Science (Professional/Scholarly Publishing (PSP) Division of American Publishers AAP/PSP), 375-398, 2002 (2002 Award Winner for the Best Book in Medical Science).

16. Kereiakes DJ and Goldschmidt-Clermont PJ, In: Contemporary Cardiology: Platelet Glycoprotein Iib/IIIa Inhibitors in Cardiovascular Disease, 2nd Edition, MA Lincoff ed., Humana Press, 383-396, 2002.

17. Dong C and Goldschmidt-Clermont PJ, Genetic Modulation of Vulnerable Plaques, In: The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management, R Virmani, J Narula, MB Leon, JT Willerson, eds., Blackwell Publishing, 350-367, 2007. (Print ISBN: 9781405158596 Online ISBN: 9780470987575)

18. Dong C, Wang L, Goldschmidt-Clermont PJ, Exercise, Cytokines and Tissue Repair, In: Cytokines, VR Preedy, R Hunter, eds., Science Publishers, USA, 47-61, 2011. (Print ISBN: 9781578086900 Online ISBN: 9781439876206)

19. Parasher, A, Goldschmidt-Clermont, PJ, Tien, JM, Healthcare Delivery as a Service System: Barriers to Co-Production and Implications of Healthcare Reform. In A. Kolker, & P. Story (Eds.), Management Engineering for Effective Healthcare Delivery: Principles and Applications (pp. 191-214). doi:10.4018/978-1-60960-872-9.ch009, 2012.

MONOGRAPHS:

1. Lincoff AM, Engel SS (co-eds), Bhatt DL, Goldschmidt-Clermont PJ, Marso SP, McGuire DK. Diabetes and Cardiovascular Disease: The Role of the Glycoprotein Iib/IIIa Inhibitors. Presented at Eli Lilly Advisory Board Meeting, Atlanta, GA, February 6, 2002.

2. Lepor NE, Kandzari DE, Goldschmidt-Clermont PJ, Kereiakes DJ, Marmur JD, Vetrovec GW. Report Card on the Pharmacologic Management of Coronary Artery Disease in the Catheterization Laboratory. Presented at Eli Lilly meeting, Chicago, IL, June 12, 2004.

ARTICLES:

1. Désir D, Féry F, Goldschmidt-Clermont P, Goldschmidt D, Van Gansbeke D, Verhoeven A. Clinical applications of an extracorporeal pancreas. Brux Med.1979 Nov-Dec; 59(11-12):497-502. French.

2. Graff GL, Gueuning C, Glupczynski Y, Goldschmidt P. Systemic effects of colchicine on phosphate metabolism in innervated and denervated, slow and fast muscles of the rat. Arch Internat Physiol Biochim. 1980; 88:393-405.

3. Goldschmidt P, Glupczynski Y, Gueuning C, Graff GL. Systemic effects of podophyllotoxin on phosphate metabolism in innervated and denervated, slow and fast muscles of the rat. Arch Internat Physiol Biochim. 1980; 88:465-74.

4. Khansari N, Petrini M, Ambrogi F, Goldschmidt-Clermont P, Fudenberg HH. Role of autorosette forming cells in antibody synthesis in vitro: suppressive activity of ARFC in humoral immune response. Immunobiology. 1984; 166(1): 1-11.

5. Goldschmidt-Clermont P, Petrini M, Khansari N, Fudenberg HH. The role of PNP enzyme in autologous rosette-forming cells. Cell Immunol. 1984; 87(2): 340-347.

6. Nel AE, Landreth GE, Goldschmidt-Clermont PJ, Tung HE, Galbraith RM. Enhanced tyrosine phosphorylation in B lymphocytes upon complexing of membrane immunoglobulin. Biochem Biophys Res Comm. 1984; 125(3):859-866.

7. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, Nel AE, Werner PM. Effect of ligand binding upon measurement of Gc by rocket immunoelectrophoresis: implications for protein determination and for studies of protein/ligand interaction. Electrophoresis. 1985; 6:155-161.

8. Lee WM, Emerson DL, Werner PM, Arnaud P, Goldschmidt-Clermont P, Galbraith RM. Decreased serum group specific component protein levels and complexes with actin in fulminant hepatic necrosis. Hepatology. 1985 Mar - Apr; 5(2):271-275.

9. Nel AE, Wooten MW, Goldschmidt-Clermont PJ, Miller PJ, Stevenson HC, Galbraith RM. Polymyxin B causes coordinate inhibition of phorbol ester-induced C-Kinase activity and proliferation of B lymphocytes. Biochem Biophys Res Comm. 1985; 128(3):1364-1372.

10. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, Marsot F, Nel AE, Arnaud P. Distinct sites on the G-actin molecule bind group-specific component and deoxyribonuclease I. Biochem J. 1985; 228:471-477.

11. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, Werner PM, Nel AM, Lee WM. Accurate quantitation of native Gc in serum and estimation of endogenous Gc:G-actin complexes by rocket immunoelectrophoresis. Clin Chim Acta. 1985; 148(3):173-183.

12. Wooten MW, Nel AE, Goldschmidt-Clermont PJ, Galbraith RM, Wrenn RW. Identification of a major endogenous substrate for phospholipid/Ca2+-dependent kinase in pancreatic acini as Gc (Vitamin D-binding protein). FEBS Lett. 1985; 191(1):97-101.

13. Nel AE, Navailles M, Emerson DL, Goldschmidt-Clermont P, Pathak SK, Tsang KY, Galbraith RM. Altered configuration of Gc on the plasma membrane of transformed and malignant human B lymphocytes. Clin Immunol Immunopathol. 1985; 37(2):191-202.

14. Nel AE, Navailles M, Rosberger DF, Landreth GE, Goldschmidt-Clermont PJ, Baldwin GJ, Galbraith RM. Phorbol ester induces tyrosine phosphorylation in normal and abnormal human B lymphocytes. J Immunol. 1985; 135(5):3448-345.

15. Nel AE, Wooten MW, Landreth GE, Goldschmidt-Clermont PJ, Stevenson HC, Miller PJ, Galbraith RM. Translocation of phospholipid/Ca2+-dependent protein kinase in B lymphocytes activated by phorbol ester or crosslinking of membranes immunoglobulin. Biochem J. 1986; 233(1):145-149.

16. Goldschmidt-Clermont PJ, Allen PC, Nel AE, Emerson DL, Day JR, Galbraith RM. Gc (Vitamin D-binding protein) binds the 33.5 K tryptic fragment of actin. Life Sci. 1986; 38(8):735-742.

17. Miribel L, Goldschmidt-Clermont P, Galbraith RM, Arnaud P. Rapid purification of native group-specific component (Vitamin D-binding protein) by differential affinity for immobilized triazine dyes. J Chromatogr. 1986; 363 (2):448-455.

18. Goldschmidt-Clermont PJ, Van Alstyne EL, Day JR, Nel AE, Emerson DL, Lazarchick J, Galbraith RM. Role of Group-specific component (vitamin D-binding protein) prevents the interaction between G-actin and profilin. Biochemistry. 1986; 25(21):6467-6472.

19. Katikaneni LP, Emerson DL, Goldschmidt-Clermont PJ, Loadholt BL, Levkoff AH, Galbraith RM. High levels of group specific component (vitamin D-binding protein) in the cerebrospinal fluid of infant aged less than two months. Biol Neonate. 1987; 52(5):250-255.

20. Krayer JW, Emerson DL, Goldschmidt-Clermont PJ, Nel AE, Werner PA, Galbraith RM. Qualitative and quantitative studies of Gc (Vitamin D-binding protein) in saliva from normals and patients with periodontal disease. J Periodont Res. 1987; 22(4):259-263.

21. Young WO, Goldschmidt-Clermont PJ, Lee WM, Emerson DL, Jollow DJ, Galbraith RM. Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating Gc (vitamin D-binding protein). J Lab Clin Med. 1987; 110(1):83-90.

22. Goldschmidt-Clermont PJ, Williams MH, Galbraith RM. Altered conformation of Gc (vitamin D-binding protein) upon complexing with cellular actin. Biochem Biophys Res Comm. 1987; 146(2):611-617.

23. Lee WM, Emerson DL, Young WO, Goldschmidt-Clermont PJ, Jollow DJ, Galbraith RM. Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis (FHN). Hepatology. 1987; 7(5):825-830.

24. Goldschmidt-Clermont PJ, Van Baelen H, Bouillon R, Shook TE, Williams MH, Nel AE, Galbraith RM. Role of group specific component (vitamin D-binding protein) in clearance of actin from the circulation in the rabbit. J Clin Invest. 1988; 81(5):1519-1527.

25. Goldschmidt-Clermont PJ, Lee WM, Galbraith RM. Proportion of circulating Gc (vitamin D-binding protein) in complexed form: relation to clinical outcome in fulminant hepatic necrosis. Gastroenterology. 1988; 94(6):1454-1458.

26. Kaiser DA, Goldschmidt-Clermont PJ, Levine BA, Pollard TD. Characterization of renatured profilin purified by urea elution from poly-l-proline agarose columns. Cell Motil Cytoskeleton. 1989; 14(2):251-262.

27. Goldschmidt-Clermont PJ, Machesky LM, Baldassare JJ, Pollard TD. The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase-C. Science. 1990; 247(4950):1575-1578.

28. Machesky LM, Goldschmidt-Clermont PJ, Pollard TD. The affinities of human platelet and Acanthamoeba profilin isoforms for polyphosphoinositides account for their relative abilities to inhibit phospholipase C. Cell Regul. 1990(12); 1:937-950.

29. Goldschmidt-Clermont PJ, Kim JW, Machesky LM, Rhee SG, Pollard TD. Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation. Science. 1991; 251(4998):1231-1233.

30. Goldschmidt-Clermont PJ, Machesky LM, Doberstein SK, Pollard TD. Mechanism of the interaction of human platelet profilin with actin. J Cell Biol. 1991(5); 113:1081-1089.

31. Goldschmidt-Clermont PJ, Janmey PA. Profilin: a weak CAP for actin and RAS. Cell. 1991; 66(3):419-421.

32. Goldschmidt-Clermont PJ, Furman MI, Wachsstock D, Safer D, Nachmias VT, Pollard TD. The control of actin nucleotide exchange by thymosinb4 and profilin. A potential regulatory mechanism for actin polymerization in cells. Mol Biol Cell. 1992; 3(9):1015-1024.

33. Goldschmidt-Clermont PJ, Mendelsohn ME, Gibbs JB. Rac and Rho in control. Current Biol. 1992; 2(12):669-671.

34. Heldman AW, Goldschmidt-Clermont PJ. Cell signalling and motile activity. Symp Soc Exp Biol. 1993;47:317-24.

35. Furman MI, Gardner TM, Goldschmidt-Clermont PJ. Mechanism of cytoskeletal reorganization during platelet activation. Thromb Haemost. 1993; 70(1):229-232.

36. Crawford LE, Tucker RW, Heldman AW, Goldschmidt-Clermont PJ. Actin regulation and surface catalysis. Adv Exp Med Biol. 1994; 358:105-112.

37. Theriot JA, Rosenblatt J, Portnoy DA, Goldschmidt-Clermont PJ, Mitchison TJ. Involvement of profilin in the actin-based motility of L. monocytogenes in cells and cell-free extracts. Cell. 1994; 76(3):505-517.

38. Finkel T, Theriot JA, Dise KR, Tomaselli GF, Goldschmidt-Clermont PJ. Dynamic actin structures stabilized by profilin. Proc Natl Acad Sci USA. 1994; 91(4):1510-1514.

39. Faraday N, Goldschmidt-Clermont P, Dise K, Bray PF. Quantitation of soluble fibrinogen binding to platelets by fluorescence activated flow cytometry. J Lab Clin Med. 1994; 123(5):728-740.

40. Gips SJ, Kandzari DE, Goldschmidt-Clermont PJ. Growth factor receptors, phospholipases, phospholipid kinases and actin reorganization. Semin Cell Biol. 1994; 5(3):201-208.

41. Sohn RH, and Goldschmidt-Clermont PJ. Profilin: at the crossroads of signal transduction and the actin cytoskeleton. Bio Essays. 1994; 16(7):465-472.

42. Furman MI, Grigoryev D, Bray PF, Dise KR, Goldschmidt-Clermont PJ. Platelet tyrosine kinase and fibrinogen receptor activation. Circ Res. 1994; 75(1):172-180.

43. Kamp TJ, Goldschmidt-Clermont PJ, Brinker JA, Resar JR. Myocardial infarction, aortic dissection, and thrombolytic therapy. Am Heart J. 1994; 128(6 pt 1):1234-1237.

44. Rosenfeld BA, Faraday N, Campbell D, Dise K, Bell W, Goldschmidt P. Hemostatic effects of stress hormone infusion. Anesthesiology. 1994; 81:1116-1126.

45. Addo JB, Bray PF, Faraday N, Grigoryev D, Goldschmidt-Clermont PJ. Surface recruitment but not activation of integrin alpha Iib beta 3 (GPIIb-IIIa) requires a functional actin cytoskeleton. Arterioscler Thromb Vasc Biol. 1995; 15(9):1466-1473.

46. Sohn RH, Chen J, Koblan KS, Bray PF, Goldschmidt-ClermontPJ. Localization of a Binding Site for Phosphatidylinositol 4,5-Bisphosphate on Human Profilin. J Biol Chem. 1995; 270(36):21114-21120.

47. Weiss EJ, Goldschmidt-Clermont PJ, Grigoryev D, Jin Y, Kickler TS, Bray PF. A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2. Tissue Antigens. 1995; 46(5):374-381.

48. Weiss EJ, Goldschmidt-Clermont PJ, Grigoryev D, Jin Y, Kickler TS, Bray PF. A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2. Tissue Antigens. 1995; 46(5):374-381.

49. Kandzari DE, Chen J, Goldschmidt-Clermont PJ. Regulation of the actin cytoskeleton by inositol phospholipid pathways. Subcell Biochem. 1996; 26:97-114.

50. Heldman AW, Tucker RW, Crawford LE, Kandzari DE, Fearon ER, Koblan KS, Goldschmidt-Clermont PJ. EJ-Ras inhibits Phospholipase C gamma1, but not actin polymerization induced by platelet-derived growth factor (PDGF)-BB via phosphatidylinositol-3 kinase. Circ Res. 1996; 78(2):312-321.

51. Melillo G, Lima JAC, Judd RM, Goldschmidt-Clermont PJ, Silverman HS. Intrinsic myocyte dysfunction and tyrosine kinase pathway activation underlie the impaired wall thickening of adjacent regions during post-infarct left ventricular remodeling. Circulation. 1996; 93(7): 1447-1458.

52. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New Engl J Med. 1996; 334(17):1090-1094.

53. Goldschmidt-Clermont PJ, Shear WS, Swartzberg J, Varga CF, Bray PF. Clues to the death of an Olympic champion. Lancet. 1996; 347 (9018): 1833.

54. Sundaresan M, Yu Z-X, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J. 1996; 318 (Pt 2): 379-382.

55. Fleischer KJ, Goldschmidt-Clermont PJ, Fonger JD, Hutchins GM, Baumgartner WA. One-month histologic response of transmyocardial laser channels with molecular intervention. Ann Thorac Surg. 1996; 62: 1051-1058.

56. Crawford LE, Milliken EE, Zweier JL, Becker L, Johnson T, Eissa NT, Crystal RG, Goldschmidt-Clermont PJ. Superoxide-mediated Actin Response in Post-Hypoxic Endothelial Cells. J Biol Chem. 1996; 271(43): 26863-26867.

57. Schulman SP, Goldschmidt-Clermont PJ, Topol EJ. The effects of Integrelin, a platelet glycoprotein Iib-IIIa receptor antagonist, in unstable angina: a randomized multicenter placebo-controlled trial. Circulation. 1996; 94: 2083-2089.

58. Goldschmidt-Clermont PJ, Schulman SP, Bray PF, Chandra NC, Grigoryev D, Dise KR, Sagar M, Fox RJ, Coleman LD, Richardson C, Dorsey F, du Mee C, Kitt MM, Baughman KL, Gerstenblith G. Refining the treatment of women with unstable angina—a randomized, double blind, comparative safety and efficacy of Integrelin versus aspirin in the management of unstable angina. Clin Cardiol. 1996; 19(11): 869-874.

59. Schecter AD, Goldschmidt-Clermont PJ, McKee G, Hoffeld D, Myers M, Velez R, Duran J, Schulman SP, Chandra NG, Ford DE. Influence of gender, race, and education on patient preferences and receipt of cardiac catheterization among coronary care unit patients. Am J Cardiol. 1996; 78(9): 996-1001.

60. Sulciner DJ, Irani K, Yu Z-X, Ferrans VJ, Goldschmidt-Clermont P, Finkel T. Rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-KappaB activation. Molec Cell Biol. 1996; 16(12): 7115-7121.

61. Moldovan NI, Milliken EE, Irani K, Chen J, Sohn RH, Finkel T, Goldschmidt-Clermont PJ. Regulation of endothelial cell adhesion by profilin. Curr Biol 1997; 7(1):24-30.

62. Takahashi A, Goldschmidt-Clermont PJ, Alnemri ES, Fernandes-Alnemri T, Yoshizawa-Kumagaya K, Nakajima K, Sasada M, Poirier GG, Earnshaw WC. Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. Exp Cell Res. 1997; 231(1):123-131.

63. Irani K, Xia Y, Zweier JL, Sollott S, Der C, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997; 275(5306):1649-1652.

64. Faraday N, Goldschmidt-Clermont PJ. Gender Differences in Platelet GPIIb-IIIa Activation. Thromb Haemost. 1997; 77(4):748-754.

65. Bray PF, Weiss EJ, Tayback M, Goldschmidt-Clermont PJ. PLA1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease. Lancet. 1997; 349(9058):1100-1101.

66. Moore KA, Sethi R, Doanes AM, Johnson TM, Pracyk JB, Kirby M, Irani K, Goldschmidt-Clermont PJ, Finkel T. Rac1 is required for cell proliferation and G2/M progression. Biochem J. 1997; 326(Pt 1):17-20.

67. Alvarez RJ, Gips SJ, Moldovan N, Wilhide CC, Milliken EE, Hoang AT, Hruban RH, Silverman HS, Dang CV, Goldschmidt-Clermont PJ. 17beta-estradiol inhibits apoptosis of endothelial cells. Biochem Biophys Res Comm. 1997; 237(2):372-381.

68. Motevalli M, Goldschmidt-Clermont PJ, Virgil D, Kwiterovich PO. Abnormal protein tyrosine phosphorylation in fibroblasts from hyperapobetalipoprotein subjects. J Biol Chem. 1997; 272:24703-24709.

69. Kelly SA; Goldschmidt-Clermont PJ; Milliken EE; Arai T; Smith EH; Bulkley GB. Protein tyrosine phosphorylation mediates TNF-induced endothelial-neutrophil adhesion in vitro. Am J Physiol. 1998; 274:H513-519.

70. Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ, Croft JB, Brown VK, Stern BJ, Feeser BR, Buchholz DW, Earley CJ, Macko RF, McCarter RJ, Sloan MA, Stolley PD, Wityk RJ, Wozniak MA, Price TR, Kittner SJ. Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: The Stroke Prevention in Young Women Study. Stroke. 1998; 29:581-585.

71. Cooke GE, Bray PF, Hamlington JD, Pham DM, Goldschmidt-Clermont PJ. PlA2 polymorphism and efficacy of aspirin. Lancet. 1998; 351:1253.

72. Arai T, Kelly SA, Brengman ML, Takano M, Smith EH, Goldschmidt-Clermont PJ, Bulkley GB. Ambient but not incremental oxidant generation effects intracellular adhesion molecule 1 induction by tumour necrosis factor in endothelium. Biochem J. 1998; 331:853-861.

73. Kim K-S, Takeda K, Sethi R, Pracyk JB, Tanaka K, Zhou YF, Yu Z-X, Ferrans VJ, Bruder JT, Kovesdi I, Irani K, Goldschmidt-Clermont P, Finkel T. Protection from reoxygenation injury by inhibition of rac1. J Clin Invest. 1998; 101(9):1821-1826.

74. Markovitz JH, Kulkami K, Goldschmidt-Clermont P, Kiefe CL, Rustagi P, Sekar P, Nanda N. Increased platelet activation and fibrinogen in Asian Indians: Potential implications for coronary risk. Eur Heart J. 1998; 19:720-726.

75. Doanes AM, Irani K, Goldschmidt-Clermont PJ, Finkel T. A requirement for rac1 in the PDGF-stimulated migration of fibroblasts and vascular smooth cells. Biochem Mol Biol Int. 1998; 45(2): 279-287.

76. Irani K, Pham Y, Coleman LD, Roos C, Cooke GE, Miodovnik A, Karim N, Wilhide CC, Bray PF, Goldschmidt-Clermont PJ. Priming of Platelet αIibβ3 by Oxidants is Associated with Tyrosine Phosphorylation of β3. Arterioscl Thromb Vasc Biol. 1998; 18:1698-1706.

77. Jones SA, Goldschmidt-Clermont PJ, Grigoryev D, Aversano T. Effect of stenosis shape on thrombus formation in an in vitro blood flow model. American Society of Mechanical Engineers, Bioenegineering Division BED. 35; 279-280.

78. Irani K and Goldschmidt-Clermont PJ. Ras, Superoxide and Signal Transduction. Biochem Pharm. 1998; 55(9):1339-1346.

79. Moldovan NI, Qian Z, Chen Y, Dong C, Ying A, Hruban RH, Flavahan NA, Baldwin III WM, Sanfilippo F, Goldschmidt-Clermont PJ. Fas-mediated apoptosis in accelerated graft arteriosclerosis. Angiogenesis. 1998; 2(3):245-254.

80. Pracyk JB, Tanaka K, Hegland DD, Kim KS, Sethi R, Rovira II, Blazina DR, Lee L, Bruder JT, Kovesdi I, Goldschmidt-Clermont PJ, Irani K, Finkel T. A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J Clin Invest. 1998; 102:929-37.

81. Goldschmidt-Clermont PJ, Moldovan L. Stress, superoxide and signal transduction. Gene Expr. 1999; 7: 255-260.

82. Kandzari DE, Goldschmidt-Clermont PJ. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1999; 281(5): 415.

83. Yeh LH, Park YJ, Hansalia RJ, Ahmed IS, Deshpande SS, Goldschmidt-Clermont PJ, Irani K, Alevriadou BR. Shear-induced tyrosine phosphorylation in endothelial cells requires Rac1-dependent production of ROS. Am J Physiol. 1999; 276(4Pt1): C838-C847.

84. Arai M, Masui Y, Goldschmidt-Clermont P, DiPaula A, Siu C, Kondo T, Becker LC. P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and 48 hours reperfusion. J Am Coll Cardiol. 1999; 34(1): 280-8.

85. Goldschmidt-Clermont PJ, Roos C, Cooke GE. P1A2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics. J Throm Thrombolysis. 1999; 8(2): 89-103.

86. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman A, Sussman MS, Ouyang P, Milliken EE, Issa PJP. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999; 43(4):985-991.

87. Moldovan L, Irani K, Moldovan, NI, Finkel T, Goldschmidt-Clermont PJ. The actin cytoskeleton reorganization induced by rac1 requires the production of superoxide. Antioxidants and Redox Signaling. 1999; 1(1): 29-43.

88. Goldschmidt-Clermont PJ, Coleman LD, Pham YM, Cooke GE, Shear WS, Weiss EJ, Kral BG, Moy TF, Yook RM, Blumenthal RS, Becker DM, Becker L, Bray PF. Higher prevalence of GPIIIa PlA2 polymorphism in siblings of patients with premature coronary heart disease. Arch Pathol Lab Med. 1999; 123(12): 1223-1229.

89. Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard MR, Kickler T, Christie DJ, Kundu S, Bray PF. Platelet GP IIIa PIA polymorphisms display different sensitivities to agonists. Circulation. 2000; 101:1013-1018.

90. Ying AK, Hassanain HH, Roos CM, Smiraglia DJ, Issa JPJ, Michler RE, Caligiuri M, Plass C, Goldschmidt-Clermont PJ. Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc Res. 2000; 46(1): 172-179.

91. Dong C, Li Z, Alvarez R, Feng ZH, Goldschmidt-Clermont PJ. Microtubule binding to Smads may regulate TGFβ activity. Mol Cell. 2000; 6(1): 27-34.

92. Qiu P, Moeschberger ML, Cooke GE, Goldschmidt-Clermont PJ. Sample size to test for interaction between a specific exposure and a second risk factor in a pair-matched case-control study. Stat Med. 2000; 10(7): 923-935.

93. Vijayan KV, Goldschmidt-Clermont PJ, Roos C, Bray PF. The P1A2 polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J Clin Invest. 2000; 105(6): 793-802.

94. Wang JH, Goldschmidt-Clermont P, Moldovan N, Yin FC. Leukotrienes and Tyrosine Phosphorylation Mediate Stretching-Induced Actin Cytoskeletal Remodeling in Endothelial Cells. Cell Motil Cytoskeleton. 2000; 46:137-145.

95. Ozaki M, Deshpande SS, Angkeow P, Bellan J, Lowenstein CJ, Cinauer MC, Goldschmidt-Clermont PJ, Irani K. Inhibition of the rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J 14(2): 418-429, 2000.

96. Moldovan L, Moldovan NI, Sohn TH, Parikh SA, Goldschmidt-Clermont PJ. Redox changes of cultured endothelial cells and actin dynamics. Circ Res. 2000; 86(5): 549-557.

97. Hassanain H, Sharma YK, Moldovan L, Khramtsov V, Berliner LJ, Duvick JP, Goldschmidt-Clermont PJ. Plant rac proteins induce superoxide in mammalian cells. Biochem Biophys Res Commun. 2000; 272(3):783-788.

98. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Start R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest. 2000; 106(4): 483-491.

99. Wang JH, Goldschmidt-Clermont P, Yin FC. Contractility affects stress fiber remodeling and reorientation of endothelial cells subjected to cyclic mechanical stretching. Ann Biomed Eng. 2000; 28(10), 1165-1171.

100. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy PE. Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res. 2000; 87(5): 378-384.

101. Boudoulas KD, Cooke GE, Roos CM, Bray PF, Goldschmidt-Clermont PJ. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med. 2001; 125(1): 112-115.

102. Dong C, Nevins J, Goldschmidt-Clermont PJ. ABCA1 single nucleotide polymorphisms. Snipping at the pathogenesis of atherosclerosis. Circ Res. 2001; 88(9): 855-7.

103. Mikkelsson J, Perola M, Penttila A, Goldschmidt-Clermont PJ, Karhunen PJ. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis. Atherosclerosis. 2001; 154(3): 721-727, 2001.

104. Goldschmidt-Clermont PJ, Kandzari DE, Khouri S, Ferrari M. Nanotechnology needs for cardiovascular sciences. Biomed Microdevices. 2001; 3:2, 83-88.

105. Bray PF, Cannon CP, Goldschmidt-Clermont P, Moyé LA, Pfeffer MA, Sacks FM, Braunwald E. The platelet P1(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol. 2001; 88: 347-352.

106. Kovacic HN, Irani K, Goldschmidt-Clermont PJ. Redox regulation of human RAC 1 stability by the proteasome in human aortic endothelial cells. J Biol Chem. 2001; 276: 45856-45861.

107. Wang J H-C, Goldschmidt-Clermont P, Wille J, Yin F C-P. Specificity of endothelial cell reorientation in response to cyclic mechanical stretching. J Biomech. 2001; 34: 1563-1572.

108. de Canniere D, Jansens JL, Goldschmidt-Clermont P, Barvais L, Decroly P, Stoupel E. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of new hybrid procedure compared with “on-pump” double bypass grafting. Am Heart J. 2001; 142(2): 563-570.

109. Nowicki PT, Flavahan S, Hassanain H, Mitra S, Holland S, Goldschmidt-Clermont PJ, Flavahan NA. Redox signaling of the arteriolar myogenic response. Circ Res. 2001; 89(2): 114-116.

110. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, Goldschmidt-Clermont PJ. Redox regulation of vascular smooth muscle cell differentiation. Circ Res. 2001; 89(1): 39-46.

111. Dong C, Goldschmidt-Clermont PJ. Ras activation of NF-kappa B and superoxide. Methods Enzymol. 2001; 333: 88-96.

112. Dong C, Zhu S, Alvarez RJ, Goldschmidt-Clermont PJ. Angiotensin II induces PAI-1 expression through MAP kinase-dependent, but TGF beta and PI3 kinase-independent pathway. J Heart Lung Transplant. 2001; 20(2): 226-227.

113. Dong C, Zhu S, Yoon W, Wang T, Alvarez RJ, Goldschmidt-Clermont PJ. Upregulation of PAI-1 is mediated through TGF-β/Smad pathway in transplant arteriopathy. J Heart Lung Transplant. 2002; 21(9):999-1008.

114. Ozaki M, Deshpande S, Angkeow P, Bellan J, Lowenstein CJ, Dinauer MC, Goldschmidt-Clermont P, Suzuki S, Irani K. Targeted inhibition of the small GTPase protects against ischemia/reperfusion liver injury in mice. Transplant Proc. 2001; 33(1-2):863-4.

115. Seshiah PN, Kereiakes DJ, Vasudevan SS, Lopes N, Su BY, Flavahan NA, Goldschmidt-Clermont PJ. Activated monocytes induce smooth muscle cell death – Role of macrophage colony-stimulating factor and cell contact. Circulation. 2002; 105: 174 -180.

116. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ, ten Dijke P, White B, Wigley FM, Goldschmidt-Clermont PJ. Deficient Smad7 expression: A putative molecular defect in scleroderma. Proc Natl Acad Sci USA. 2002; 99: 3908-3913. [Retracted in 2016 at the request of the senior author PJGC for suspicion of data fabrication for figure 3. See 226 for comment]

117. Lopes N, Vasudevan SS, Alvarez RJ, Binkley PF, Goldschmidt PJ. Pathophysiology of plaque instability: Insights at the genomic level. Prog in Cardiovasc Dis. 2002; 44: 323-338.

118. Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, Jones J, Goldschmidt-Clermont PJ, Loscalzo J. Heterozygous cellular glutathione peroxidase deficiency in the mouse: Abnormalities in vascular and cardiac function and structure. Circulation. 2002; 106 (9): 1154-1158.

119. Wang T, Dong C, Stevenson SC, Herderick EE, Marshall-Neff J, Vasudevan SS, Moldovan NI, Michler RE, Movva NR, Goldschmidt-Clermont PJ. Overexpression of Soluble Fas attenuates transplant arteriosclerosis in rat aortic allografts. Circulation. 2002; 106 (12):1536-1542.

120. Dong C, Yoon W, Goldschmidt-Clermont PJ. DNA methylation and atherosclerosis. J Nutr. 2002; 132: 2406S-2409S.

121. Goldschmidt-Clermont PJ. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries. J Invasive Cardiol. 2002; 14 (Suppl E): 1E-10E.

122. Goldschmidt-Clermont PJ, Kandzari DE, Sketch MH, Phillips HR. Inflammation, platelets and glycoprotein IIb/IIIa inhibitors. J Invasive Cardiol. 2002; 14 (Suppl E): 18E-25E.

123. Mayes CE, Kandzari DE, Goldschmidt-Clermont PJ, Phillips HR. The complementary use of glyprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention. J Invasive Cardiol. 2002; 14 (Suppl E): 36E-46E.

124. Lopes NH, Vasudevan SS, Gregg D, Selvakumar B, Pagano PJ, Kovacic H, Goldschmidt-Clermont PJ. Rac-dependent monocyte chemoattractant protein-1 production is induced by nutrient deprivation. Circ Res. 2002; 91(9): 798-805.

125. Kandzari DE, Goldschmidt-Clermont PJ. Making positive out of negative trials. Am Heart J. 2002; 143: 950-951.

126. Dong C, Goldschmidt-Clermont PJ. E2F1: A magic bullet for atherosclerosis? Circulation. 2002; 106: 2640-2641.

127. Lopes N, Gregg D, Vasudevan S, Hassanain H, Goldschmidt-Clermont P, Kovacic H. Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling. Mol Cell Biol. 2003; 23: 5401-5408.

128. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA. Aging, vascular progenitor cell exhaustion and atherosclerosis. Circulation. 2003; 108: 457-463.

129. Gregg D, Rauscher FM, Goldschmidt-Clermont PJ. Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol Cell Physiol. 2003; 285: C723-C734.

130. Vasudevan SS, Lopes N, Seshiah PN, Wang T, Marsh CB, Kereiakes DJ, Dong C, Goldschmidt-Clermont PJ. Mac-1 and Fas activities are concurrently required for execution of smooth muscle cell death by M-CSF-stimulated macrophages. Cardiovasc Res. 2003; 59: 723-733.

131. Kurrelmeyer K, Becker L, Becker D, Yanek L, Goldschmidt-Clermont P, Bray PF. Platelet hyperreactivity in women from families with premature atherosclerosis. J of Am Med Women’s Assoc. 2003; 58: 272-277.

132. Goldschmidt-Clermont PJ, Peterson ED. On the memory of a chronic illness. Sci Aging Knowledge Environ. 2003; (45), re8.

133. Goldschmidt-Clermont PJ. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis. Am Heart J. 2003; 146:S5-12.

134. French JK, Van de Water NS, Sutton TM, Lund M, Gao W, McDowell J, Liu-Stratton Y, Pohorence J, Szymanski D, Goldschmidt-Clermont P, White HD, Browett PJ, Cooke G. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction. Am Heart J. 2003; 145(1): 118,124.

135. Gregg D, Goldschmidt-Clermont PJ. Platelets and cardiovascular disease. Circulation. 2003; 108:e88-e90.

136. Burr D, Doss H, Cooke GE, Goldschmidt-Clermont PJ. A meta-analysis of studies on the association of the platelet P1A polymorphism of glycoprotein IIIa and risk of coronary heart disease. Stat Med. 2003; 22(10): 1741-1760.

137. Vijayan KV, Huang TC, Liu Y, Bernardo A, Dong JF, Goldschmidt-Clermont PJ, Alevriadou BR, Bray PF. Shear stress augments the enhanced phenotype of cells expressing the Pro33 isoform of integrin beta3. FEBS Lett. 2003; 540(1-3): 41-46.

138. Williams RS, Goldschmidt-Clermont PJ. The genetics of cardiovascular disease: from genotype to phenotype. Dialogues in Cardiovascular Medicine. 2004; 9(1): 3-19.

139. Zhu S, Goldschmidt-Clermont PJ, Dong C. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability. Circ Res. 2004; 94(5):617-625.

140. Califf RM, Ryan T, Douglas P, Goldschmidt-Clermont PJ. A time of accelerated change in academic cardiovascular medicine. J Am Coll Cardiol. 2004; 44:1957-1965.

141. Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, Vata K, Schulteis R, Milano CA, Rigat F, Pittman J, Nevins JR, West M, Goldschmidt-Clermont PJ. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24 (10): 1922-1927.

142. Dai Q, Huang J, Klitzman B, Dong C, Goldschmidt-Clermont PJ, March KL, Rokovich J, Johnstone B, Rebar EJ, Spratt SK, Case CC, Kontos CD, Annex BH. Engineered zinc finger- activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hind-limb ischemia. Circulation. 2004; 110(16): 2467-2475.

143. Goldschmidt-Clermont PJ, Lam G, Dong C. Progenitor cell dysfunction: A key trigger for atherosclerotic inflammation. Drug Dis Today: Dis Mech. 2004; 1(1), pp. 53-58.

144. Hassanain HH, Irshaid F, Wisel S, Sheridan J, Michler RE, Goldschmidt-Clermont PJ. Smooth muscle cell expression of a constitutive active form of human Rac 1 accelerates cutaneous wound repair. Surgery. 2005; 137:92-101.

145. Dong C, Crawford LE, Goldschmidt-Clermont PJ. Endothelial progenitor obsolescence and atherosclerotic inflammation. J Am Coll Cardiol. 2005; 45:1458-1460.

146. Ajijola OA, Goldschmidt-Clermont PJ, Satterwhite LL. CD40 ligand: not bad to the bone (marrow) after all. Arterioscler Thromb Vasc Biol. 2005; 25(6): 1088-1090.

147. Karra R, Vemullapalli S, Dong C, Herderick EE, Nevins JR, West M, Goldschmidt-Clermont PJ, Seo D. Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci USA. 2005; 102 (46):16789-94.

148. Goldschmidt-Clermont PJ, Creager MA, Losordo DW, Lam GK, Wassef M, Dzau VJ. Atherosclerosis 2005: Recent discoveries and novel hypotheses. Circulation. 2005; 112 (21):3348-53.

149. Kong DF, Goldschmidt-Clermont PJ. Tiny solutions for giant cardiac problems. Trends in Cardiovasc Med. 2005; 15(6):207-11.

150. Zhu S, Goldschmidt-Clermont PJ, Dong C. Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation. 2005; 112 (9): 1353-61.

151. Liu X, Zhu S, Wang T, Hummers L, Wigley F, Goldschmidt-Clermont PJ, Dong C. Paclitaxel modulates TGF. Signaling in scleroderma skin grafts in immunodeficient mice. Plos Med. 2005; 2(12): e354.

152. Goldschmidt-Clermont PJ, Diehl AM. Arterial homeostasis, inflammation, and erythropoietic growth factors. Rev Cardiovasc Med. 2005; 6 Suppl 3:S22-6.

153. Kravchenko J, Goldschmidt-Clermont PJ, Powell T, Stallard E, Akushevich I, Cuffe MS, Manton KG. Endothelial progenitor cell therapy for atherosclerosis: The philosopher’s stone for an aging population? Sci Aging Knowledge Environ 2005; 25:18.

154. Stenger JE, Xu H, Haynes C, Hauser ER, Pericak-Vance M, Goldschmidt-Clermont PJ, Vance JM. Statistical viewer: a tool to upload and integrate linkage and association data as plots displayed within the Ensembl genome browser. BMC Bioinformatics. 2005; 12(6), 95.

155. Cooke GE, Liu-Stratton Y, Ferketich AK, Moeschberger ML, Frid DJ, Magorien RD, Bray PF, Binkley PF, Goldschmidt-Clermont PJ. Effect of inhibition by aspirin, clopidogrel, or their combination. J Am Coll Cardiol. 2006; 47(3):541

156. Niu J, Azfer A, Deucher MF, Goldschmidt-Clermont PJ, Kolattukudy PE. Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1. J Mol Cell Cardiol. 2006; 40(6):810-20.

157. Moldovan L, Mythreye K, Goldschmidt-Clermont PJ, Satterwhite LL. Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1. Cardiovasc Res. 2006; 15; 71(2):236-46.

158. Boudoulas KD, Montague KR, Goldschmidt-Clermont PJ, Cooke GE. Estradiol increases platelet aggregation in PlA1/A1 individuals. Am Heart J. 2006; 152(1):136-9.

159. Seo D, Ginsburg GS, Goldschmidt-Clermont PJ. Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. J Am Coll Cardiol. 2006; 18; 48(2):227-35.

160. Connelly JJ, Wang T, Cox JE, Haynes C, Wang L, Shah SH, Crosslin DR, Hale AB, Nelson S, Crossman DC, Granger CB, Haines JL, Jones CJ, Vance JM, Goldschmidt-Clermont PJ, Kraus WE, Hauser ER, Gregory SG. GATA2 Is Associated with Familial Early-Onset Coronary Artery Disease. PLoS Genet. 2006: 25; 2(8).

161. Montague CR, Hunger MG, Gavrilin MA, Phillips GS, Goldschmidt-Clermont PJ, Marsh, CB. Activation of Estrogen Receptor Alpha Reduces Aortic Smooth Muscle Differentiation. Circ Res. 2006; 99(5):477-84.

162. Donahue MP, Rose K, Hochstrasser D, Vonderscher J, Grass P, Chibout SD, Nelson CL, Sinnaeve P, Goldschmidt-Clermont PJ, Granger CB. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am Heart J. 2006; 152 (3):478-85.

163. Kim J, Kim JY, Song KY, Lee YH, Seo JS, Jelinek J, Goldschmidt-Clermont PJ, Issa, JP. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta. 2006 Oct 12.

164. Cooke G, Goldschmidt-Clermont PJ. The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease. Expert Opin. Drug Saf. 2006; 5(6):815-26.

165. Kunz GA, Liang G, Cuculoski F, Gregg D, Vata KC, Shaw LK, Goldschmidt-Clermont PJ, Dong C, Taylor DA, Peterson ED. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J. 2006; 152(1):190-5.

166. Choi SS, Sicklick JK, Ma Q, Yang L, Huang J, Qi Y, Chen W, Li YX, Goldschmidt-Clermont PJ, Diehl AM. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. Hepatology. 2006; 44(5):1267-77.

167. Zhu S, Liu X, Li Y, Goldschmidt-Clermont PJ, Dong C. Aging in the Atherosclerosis Milieu May Accelerate the Consumption of Bone Marrow Endothelial Progenitor Cells. Arterioscler Thromb Vasc Biol. 2007; 27(1):113-9.

168. Hassanain HH, Gregg D, Marcelo ML, Zweier JL, Souza HP, Selvakumar B, Ma Q, Moustafa-Bayoumi M, Binkley PF, Flavahan NA, Morris M, Dong C, Goldschmidt-Clermont PJ. Hypertension Caused by Transgenic Over-expression of Rac1. Antioxidants & Redox Signaling. 2007; 9(1):91-100.

169. Seo DM, Goldschmidt-Clermont PJ. Unraveling the genetics of atherosclerosis: implications for diagnosis and treatment. Expert Rev Mol Diagn. 2007; 7(1):45-51.

170. Vemulapalli S, Metzler SD, Akabani G, Petry NA, Niehaus NJ, Liu X, Patil NH, Greer KL, Jaszczak RJ, Coleman RE, Dong C, Goldschmidt-Clermont PJ, Chin BB. Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT. Radiology. 2007; 242(1):198-207.

171. Wang L, Vance J, Pericak-Vance M, Shah S, Hauser ER, Goldschmidt-Clermont PJ, Krauss WE. Peak-wide mapping on chromosome 3q13 identifies the kalirin gene as a novel susceptibility gene for coronary artery disease. American Journal of Human Genetics. 2007; 80(4):650-63.

172. Dong C, Goldschmidt-Clermont PJ. Endothelial progenitor cells: A promising therapeutic alternative for cardiovascular disease. J Interv Cardiol. 2007; 20(2):93-9.

173. Seo DM, Goldschmidt-Clermont PJ, West M. Of Mice and Men: Sparse Statistical Modeling in Cardiovascular Genomics. Annals of Applied Statistics. 2007; Vol. 1, No. 1, 152-178.

174. Tabatabaei N, Stout J, Goldschmidt-Clermont P, Murdoch D. Central Nervous System Infection and Cutaneous Lymphadenitis Due to Mycobacterium kansasii in an Immunocompetent Patient. Infection. 2007;35(4):291-4.

175. Moustafa-Bayoumi M, Alhaj MA, El-Sayed O, Wisel S, Chotani MA, Aboelnaga ZA, Hassona MD, Morris M, Nuovo G, Zweier JL, Goldschmidt-Clermont P, Hassanain H. Vascular hypertrophy and hypertension caused by transgenic over expression of profilin 1. J Biol Chem. 2007; 282 (52):337632-9.

176. Liao SM, Goldschmidt- Clermont PJ, Sugarman J. Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. J Med Ethics. 2007; 33(11):643-6.

177. Povsic TJ, Zavodni KL, Kelly FL, Zhu S, Goldschmidt-Clermont PJ, Dong C, Peterson ED. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol. 2007; 50(23):2243-8.

178. Seo D, Goldschmidt-Clermont PJ. Cardiovascular genetic medicine: the genetics of coronary heart disease. J Cardiovasc Transl Res. 2008 Jun; 1(2):166-70. Epub 2008 May 23. Review.

179. Shah SH, Hauser ER, Crosslin D, Wang L, Haynes C, Connelly J, Nelson S, Johnson J, Gadson S, Nelson CL, Seo D, Gregory S, Kraus WE, Granger CB, Goldschmidt-Clermont P, Newby LK. ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. Atherosclerosis. 2008 Nov; 201(1):148-54.

180. Wang H, Yan B, Satterwhite LL, Ma Q, Goldschmidt-Clermont PJ. Increased activity of phosphatase PP2A in the presence of the PlA2 polymorphism of alphaIIbbeta3. Biochem Biophys Res Commun. 2008; 367 (1): 72-77

181. Sutton BS, Crosslin DR, Shah SH, Nelson SC, Bassil A, Hale AB, Haynes C, Goldschmidt-Clermont PJ, Vance JM, Seo D, Kraus WE, Gregory SG, Hauser ER. Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Hum Mol Genet. 2008; 17 (9): 1318-28.

182. Selvakumar B, Hess D, Goldschmidt-Clermont PJ, Stamler J. Co – regulation of constitutive nitric oxide synthases and NADPH oxidase by the small GTPase Rac. FEBS Lett. 582 (2008) 2195-2202.

183. Povsic T, Goldschmidt-Clermont PJ. Review: Endothelial progenitor cells: markers of vascular reparative capacity. Therapeutic Advances in Cardiovascular Disease. 2008; 2; 199-213.

184. Goldschmidt-Clermont PJ. Dong C, West M, Seo D. Of Cardiovascular Illness and Diversity of Biological Response. Trends in Cardiovascular Medicine. 2008; 18(5): 194-197.

185. Wang L, Hauser ER, Shah SH, Seo D, Sivashanmugam P, Exum ST, Gregory SG, Granger CB, Haines JL, Jones CJ, Crossman D, Haynes C, Kraus WE, Freedman NJ, Pericak-Vance MA, Goldschmidt-Clermont PJ, Vance JM. Polymorphisms of the Tumor Suppressor Gene LSAMP are Associated with Left Main Coronary Artery Disease. Ann Hum Genet. 2008;72(Pt 4): 443-53.

186. Goldschmidt-Clermont PJ, Dong C. Contrast Enhanced MRI as the Newest Tool to Detect Transplant Coronary Artery Disease. J Am Coll Cardiol. 2008; 52(14): 1168-1169.

187. Mythreye K, Satterwhite LL, Davidson WS, Goldschmidt-Clermont PJ. ApoA-I Induced CD31 in Bone Marrow-derived Vascular Progenitor Cells Increases Adhesion: Implications for Vascular Repair. Biochimica Biophysica Acta. 2008; 1781 (11-12): 703-709.

188. Zhu S, Evans S, Yan B, Povsic T, Tapson V, Goldschmidt-Clermont PJ, Dong C. Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum Induced Apoptosis in Endothelial Progenitor Cells. Circulation. 2008, 118(21):2156-65.

189. Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, Johnson J, Nelson S, Wang L, Connelly JJ, Muehlbauer M, Ginsburg GS, Crossman DC, Jones CJ, Vance J, Sketch MH, Granger CB, Newgard CB, Gregory SG, Goldschmidt-Clermont PJ, Kraus WE, Hauser ER. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet. 2009 Jan; 5(1):e1000318.

190. Ajijola OA, Dong C, Herderick EE, Ma Q, Goldschmidt-Clermont PJ, Yan Z. Voluntary Running Suppresses Proinflammatory Cytokines and Bone Marrow Endothelial Progenitor Cell Levels in Apolipoprotein-E-Deficient Mice. Antioxidants & Redox Signaling. 2009; 11(1):15-23.

191. Povsic TJ, Zavodni KL, Vainorius E, Kherani JF, Goldschmidt-Clermont PJ, Peterson ED. Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations. Am Heart J. 2009; 157(2):335-44.

192. Crosslin DR, Shah SH, Nelson SC, Haynes CS, Connelly JJ, Gadson S, Goldschmidt-Clermont PJ, Vance JM, Rose J, Granger CB, Seo D, Gregory SG, Kraus WE, Hauser ER. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum Genet. 2009; 125(2):217-29.

193. Seo D, Goldschmidt-Clermont PJ. The Paraoxonase Gene Family and Atherosclerosis. Current Atherosclerosis Reports. 2009, 11:182-187. Review.

194. Ma Q, Cavallin L, Yan B, Zhu S, Duran E, Wang H, Hale L, Dong C, Cesarman E, Mesri E, Goldschmidt-Clermont PJ. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci USA, 2009, 26;106(21):8683-8.

195. Tien J and Goldschmidt-Clermont PJ. Healthcare: A Complex Service System. J Syst Sci Syst Eng, 2009, 18(3):257-282.

196. Sinnaeve P, Donahue M, Grass P, Seo D, Vonderscher J, Chibout S, Kraus W, Sketch M, Nelson C, Ginsburg G, Goldschmidt-Clermont PJ, Granger C. Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease. PLoS One, 2009, 4(9):e7037, 2009.

197. Goldschmidt-Clermont PJ, Dong C, Rhodes N, McNeill D, Adams M, Gilliss C, Cuffe, M, Califf R, Peterson E, Lubarsky D. Perspective: Autonomic Care Systems for Hospitalized Patients. Academic Medicine. 2009 Dec;84(12):1727-31.

198. Rodriguez-Menocal L, Wei Y, St-Pierre M, Li S, Pham S, Webster K, Goldschmidt-Clermont P, Vazquez-Padron R. A Novel Mouse Model of In-Stent Restenosis. Atherosclerosis. 2010 Apr; 209(2):359-66. Epub 2009 Oct 6.

199. Liu X, Li Y, Liu Y, Luo Y, Wang D, Annex BH, Goldschmidt-Clermont PJ. Endothelial Progenitor Cell (EPCs) Mobilized and Activated by Neurotrophic Factors May Contribute to Pathologic Neovascularization in Diabetic Retinopathy. Am J Pathol. 2010 Jan; 176(1):504-15.

200. Goldschmidt-Clermont PJ, Dong C, Seo DM, Velazquez OC: Atherosclerosis, inflammation, genetics, and stem cells: 2012 update. Curr Atheroscler Rep; 2012 Jun;14(3):201-10 PMID: 22476914

201. Ginzburg E, O’Neill WW, Goldschmidt-Clermont PJ, de Marchena E, Pust D, Green BA. Rapid Medical Relief – Project Medishare and the Haitian Earthquake. N Engl J Med. 2010 Mar 11; 362(10):e31.

202. Hassona MDH, Abouelnaga ZA, Abdulrahman B, Elnakish MTM, Alhaj MA, Goldschmidt-Clermont PJ, Hassanain H. Vascular Hypertrophy-associated Hypertension of Profilin 1 Transgenic Mouse Model Leads to Functional Remodeling of Peripheral Arteries. Am J of Physiology. 2010 June; 298(6):H2112-20. Epub 2010 Apr 16.

203. Zhu S, Malhotra A, Zhang L, Deng S, Zhang T, Freedman NJ, Storms R, Peppel K, Goldschmidt-Clermont PJ, Dong C. Human Umbilical Cord Blood Endothelial Progenitor Cells Decrease Vein Graft Neointimal Hyperplasia in SCID Mice. Atherosclerosis. 2010 Sep;212(1):63-9.

204. Seo D, Goldschmidt-Clermont PJ, Velazquez O, Beecham G. Genomics of Premature Atherosclerotic Vascular Disease. Curr Atheroscler Rep. 2010 May; 12(3):187-93.

205. Tien JM, Goldschmidt-Clermont PJ. Engineering healthcare as a service system. Stud Health Technol Inform. 2010; 153:277-97.

206. Chen GL, Dong C, Goldschmidt-Clermont PJ. Journey in Antithrombotic Strategies for ST-Elevation Myocardial Infarction. Critical Pathways in Cardiology. 2010 Dec; 9(4):235-242.

207. Goldschmidt-Clermont PJ, Seo DM, Wang L, Beecham GW, Liu ZJ, Vazquez-Padron RI, Dong C, Hare JM, Kapiloff MS, Bishopric NH, Pericak-Vance M, Vance JM, Velazquez OC. Inflammation, stem cells and atherosclerosis genetics. Current Opinion in Molecular Therapeutics. 2010; 12(6):712-723.

208. Minear MA, Crosslin DR, Sutton BS, Connelly JJ, Nelson SC, Gadson-Watson S, Wang T, Seo D, Vance JM, Sketch MH, Haynes C, Goldschmidt-Clermont PJ, Shah SH, Kraus WE, Hauser ER, Gregory SG. Polymorphic variants in tenascin C (TNC) are associated with atherosclerosis and coronary artery disease. Human Genetics, 2011 Jun;129(6):641-54. Epub 2011 Feb 5.

209. Cesar L, Suarez SV, Adi J, Adi N, Vazquez-Padron R, Yu H, Ma Q, Goldschmidt-Clermont PJ, Agatston A, Kurlansky P, Webster KA.An essential role for diet in exercise-mediated protection against dyslipidemia, inflammation and atherosclerosis in ApoE-/- Mice. PLoS One. 2011 Feb 16;6(2):e17263.

210. Skartsis N, Manning E, Wei Y, Velazquez OC, Liu ZJ, Goldschmidt-Clermont PJ, Salman LH, Asif A, Vazquez-Padron RI. Origin of neointimal cells in arteriovenous fistulae: bone marrow, artery, or the vein itself? Semin Dial, 2011 Mar; 24(2):242-8.

211. Song X, Ma Q, Liu X, Seo P. Herderick E, Webster K, Goldschmidt-Clermont PJ, Seo D. Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis? Antioxid Redox Signal. 2012 Jan 1; 16(1):85-91. Epub 2011 Sep 22.

212. Nolan DK, Sutton B, Haynes C, Johnson J, Sebek J, Dowdy E, Crosslin D, Crossman D, Sketch MH Jr, Granger CB, Seo D, Goldschmidt-Clermont PJ, Kraus WE, Gregory SG, Hauser ER, Shah SH. Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. BMC Genet. 2012 Feb 27;13:12.

213. Goldschmidt PJ, Dong C, Seo D, Velazquez O. Atherosclerosis, Inflammation, Genetics and Stem Cells, 2012 Update. Current Atherosclerosis Report. 2012 Jun;14(3):201-10. Epub 2012 April 3.

214. Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak-the link between depression and cardiovascular disease. Nat Rev Cardio. 2012 Jun 26. 2012 Sep;9(9):526-39

215. Liu ZJ, Tan Y, Beecham GW, Seo DM, Tian R, Li Y, Vazquez-Padron RI, Pericak-Vance M, Vance JM, Goldschmidt-Clermont PJ, Livingstone AS, Velazquez OC. Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis. Atherosclerosis. 2012 Dec; 225(2):296-303

216. Ma Q, Cavallin LE, Leung HJ, Chiozzini C, Goldschmidt-Clermont PJ, Mesri EA. A role for virally induced reactive oxygen species in Kaposi’s sarcoma herpesvirus tumorigenesis. Antioxid Redox Signal. 2013 Jan 1;18(1):80-90.

217. Zhu S, Deng S, Ma Q, Zhang T, Jia C, Zhuo D, Yang F, Wei J, Wang L, Dykxhoorn DM, Hare JM, Goldschmidt-Clermont PJ, Dong C. microRNA-10A* and microRNA-21 Modulate Endothelial Progenitor Cell Senescence via Suppressing Hmga2. Circ Res. 2013 Jan 4;112(1):152-64. Epub 2012 Oct 16

218. Clouse A, Deo S, Rampersaud E, Farmer J, Goldschmidt-Clermont P, Daunert S. Defining a Molecular Portrait of Physical Fitness. Anal Bioanal Chem. 2013 Jan;405(1):21-6.2012

219. Rampersaud E, Nathanson L, Farmer J, Meshbane K, Belton RL, Dressen A, Cuccaro M, Musto A, Daunert S, Deo S, Hudson N, Vance JM, Seo D, Mendez A, Dykxhoorn DM, Pericak-Vance MA, Goldschmidt-Clermont PJ. Genomic signatures of a global fitness index in a multi-ethnic cohort of women. Ann Hum Genet. 2013 Mar; 77(2):147-57. Epub 2013 Jan 7

220. Andreev VP, Head T, Johnson N, Deo SK, Daunert S, Goldschmidt-Clermont PJ. Discrete event simulation model of sudden cardiac death predicts high impact of preventive interventions. . Sci Rep. 2013;3:1771

221. Connelly JJ, Cherepanova OA, Doss JF, Karaoli T, Lillard TS, Markunas CA, Nelson S, Wang T, Ellis PD, Langford CF, Haynes C, Seo DM, Goldschmidt-Clermont PJ, Shah SH, Kraus WE, Hauser ER, Gregory SG. Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis. Hum Mol Genet. 2013 Dec 20;22(25):5107-20

222. Mesri EA, Cavallin LE, Ashlock BM, Leung HJ, Ma Q, Goldschmidt-Clermont PJ. Molecular studies and therapeutic targeting of Kaposi’s sarcoma herpesvirus (KSHV/HHV-8) oncogenesis. Immunol Res. 2013 Dec;57(1-3):159-65

223. Vance DD, Chen GL, Stoutenberg M, Myerburg RJ, Jacobs K, Nathanson L, Perry A, Seo D, Goldschmidt-Clermont PJ, Rampersaud E. Cardiac performance, biomarkers and gene expression studies in previously sedentary men participating in half-marathon training. BMC Sports Sci Med Rehabil. 2014 Feb 19;6(1):6.

224. Cavalin LE, Goldschmidt-Clermont P, Mesri EA. Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS. PLoS Pathoq. 2014 Jul 10;10(7):e1004154.

225. Beecham AH, Wang L, Vasudeva N, Liu Z, Dong C, Goldschmidt-Clermont PJ, Pericak-Vance MA, Rundek T, Seo D, Blanton SH, Sacco RL, Beecham GW. Utility of blood pressure genetic risk score in admixed Hispanic samples. J Hum Hypertens. 2016 Jun 2. doi: 10.1038/jhh.20

226. Retraction for “Deficient Smad7 expression: A putative molecular defect in scleroderma,” by Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ, ten Dijke P, White B, Wigley FM, Goldschmidt- Clermont PJ, which appeared in issue 6, March 19, 2002, of Proc Natl Acad Sci USA (99:3908–3913; 10.1073/pnas.062010399) Proc Natl Acad Sci USA. 113:15, April 12, 2016. This work was submitted and reviewed during my transition from Ohio State to Duke University. An additional figure, Figure 3, was requested by the reviewers. My research team, still in Ohio then, was charged with performing the required experiments. I did not verify the primary material that was used to prepare the figure 3. It was a very busy time for me as I had just moved to Duke as Chief of Cardiology. I had entrusted my team to do the work responsibly and ethically, and I take full responsibility for my mistake and for what has happened. Unfortunately, due to the 15 years gap between the performance of the work, and the discovery of fabrication, I could not review the original data and identify, for sure, who was responsible for the fabrication. Out of my 237 scientific reports to date, this is the only one for which an ethical issue has damaged our work. It is one too many, and I deeply regret it. PJGC.

227. Golpanian S, DiFede DL, Pujol MV, Lowery MH, Levis-Dusseau S, Goldstein BJ, Schulman IH, Longsomboon B, Wolf A, Khan A, Heldman AW, Goldschmidt-Clermont PJ, Hare JM. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. Oncotarget. 2016 Mar 15;7(11):11899-912. doi: 10.18632/oncotarget.7727.

228. Tien JM, Goldschmidt-Clermont PJ. The Case for Technobiology: A Complement to Biotechnology. World Automation Congress Proceedings 2016-October,7582989.

229. Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Pujol MV, Da Fonseca M, Oliva AA Jr, Green G, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Goldschmidt-Clermont PJ, Hare JM. Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci. 2017 Apr 21. doi: 10.1093/gerona/glx056. [Epub ahead of print] PMID: 28444181

230. Goldschmidt-Clermont PJ, Haseltine WA. Evolving the role of nursing in the twenty first century: leading the team. Annals of Women’s Health | Volume 1 | Issue 1 | Article 1001. 2017

231. Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Pujol MV, Da Fonseca M, Oliva AA Jr, Green G, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Goldschmidt-Clermont PJ, Hare JM. Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci. 2017 Apr 21. doi: 10.1093/gerona/glx056. [Epub ahead of print] PMID: 28444181

232. Daunert, S, Sittampalam GS, Goldschmidt-Clermont PJ. Twenty-First Century Diseases: Commonly Rare and Rarely Common? Antioxidants & Redox Signaling 2017 Sep 20;27(9):511-516. doi: 10.1089/ars.2017.7065. Epub 2017 Jul 5.

233. Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Bymes JJ, Lauwery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Da Fonseca M, Golpanian S, Premer C, Medina A, Valasaki K, FolreaV, Anderson E, El Khorazaty J, Mendizabal A, Green G, Oliva AA, Hare JM. Allogeneic mesenchymal stem cells ameliorate aging frailty. A phase II randomized, double-blind, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 2017 1-9 doi: 10.1093/gerona/glx137. [Epub ahead of print]

234. Knaul FM, Farmer PE, Krakauer EL, et al.; Lancet Commission on Palliative Care and Pain Relief Study Group. Goldschmidt-Clermont PJ, commissioner. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2017 Oct 11. pii: S0140-6736(17)32513-8. doi: 10.1016/S0140-6736(17)32513-8. [Epub ahead of print]

235. Liu Z, Pericak-Vance MA, Goldschmidt-Clermont P, Seo D, Wang L, Rundek T, Beecham GW. Coronary collateralization shows sex and racial-ethnic differences in obstructive artery disease patients. PLoS One. 2017 Oct 10;12(10):e0183836. doi: 10.1371/journal.pone.0183836. eCollection 2017.

236. Head T, Daunert S, Goldschmidt-Clermont, PJ. The aging risk and atherosclerosis: a fresh look at arterial homeostasis. Front Genet. Doe: 10.3389/fgene.2017.00216, 2017.

237. Magnani DM, Rogers TF, Maness NJ, Grubaugh NG, Beutler N, Bailey VK, Gonzalez-Nieto L, Gutman MJ, PedreñoLopez N, Kwal JM, Ricciargi MJ, Myers TA, Julander JG, Bohm RP, Gilbert MH, Schiro F, Aye PP, Blair RV, Martins MA, Falkenstein KP, Kaur A, Curry CL, Kallas EG, Desrosiers RC, Goldschmidt-Clermont PJ, Whitehead SS, Andersen KG, Bonaldo MC, Lackner AA, Panganiban AT, Burton DR, Watkins DI. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. Nat. Common. Dog: 10.1038/s41467-018-04056-4, 2018.

238. Cavalin LE, … Goldschmidt-Clermont PJ, Mesri E. KSHV-induced ligand medicated activation of PDGF receptor-alpha drives Kaposi’s sarcomagenesis. PLoS Pathogens, EMID:5e#2663d012c1a8a, 2018.

239. Goldschmidt-Clermont PJ. e-Letter: "Healed by ROS". Science Signaling. http://stke.sciencemag.org/content/11/523/eaat1605/tab-e-letters, 2018.

240. Head T, Henn L, Andreev V, Herderick E, Deo SK, Daunert S, Goldschmidt-Clermont PJ. Accelerated Coronary Atherosclerosis Not Explained by Traditional Risk Factors in Thirteen Percent of Young Individuals. Am Heart J. Am Heart J, 208:47-54. doi: 10.1016/j.ahj.2018.11.005. Epub 2018 Nov 13. 2019.

241. Goldschmidt-Clermont PJ, Volinsky FG, LaRosa SP, Gilbert JR, Periçak-Vance MA. Time for Well-Powered Controlled Prospective Studies to Test a Causal Role for Herpes Viruses in Alzheimer’s Disease Using Antiherpetic Drugs, The Journals of Gerontology: Series A, https://doi.org/10.1093/gerona/glz150. 2019.

242. Goldschmidt-Clermont PJ, Romet-Lemonne J-L, Fontanet A, Stevenson M. (2019) Virus Cooperation, ZIKV Viremia and In Utero Fetus Infection. J Women Health Care Issues 2(2): https://www.auctoresonline.org/journals/women-health-care-and-issues/article-in-press, 2019.

243. Goldschmidt-Clermont PJ, DiFede DL, White I. e-Letter: Amniotic Exosome and Pregnancy. Science Translational Medicine 11, Issue 492, eaav8521 (doi: 10.1126/scitranslmed.aav8521), 2019.

244. Nipauer J, Rosario S, Gupta S, Premer C, Mendez O, Schlesinger M, Ponzinibbio V, Vaibhav J, Gay L, Renne R, Chan HL, Marey Lluis, Salyakina D, Abba M, Williams S, Hare JM, Goldschmidt-Clermont PJ, Mesri E. PDGFRA defines the mesenchymal stem cell Kaposi’s sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment. Plos Pathogen, in press, 2019.

245. Goldschmidt-Clermont PJ. COVID-19 Real-World data for the US and lessons to re-open business. Pre-print, medRxiv https://www.medrxiv.org/content/10.1101/2020.06.02.20120618v1, 2020

246. Goldschmidt-Clermont PJ. COVID-19 Real-World data for the US and lessons to re-open business. PLoS-Patog 16(8): e1008756. https://doi.org/10.1371/journal.ppat.1008756 2020.

247. Goldschmidt-Clermont PJ, Goldschmidt AJP, Weiss RE. Rivalry between human ideation and virus mutation: two competing means of sustainability. J Women Health Care Issues 4(3) Doi: 10.31579/2642-9756/058; 2021.

248. Gonzalez MJ, Kweh MF, Biava PM, Olalde J, Toro AP, Goldschmidt-Clermont PJ, White IA. Evaluation of exosome derivatives as bio-informational reprogramming therapy for cancer. J Transl Med 19:103 Doi: 10.1186/s12967-021-02768-8; 2021.

249. Goldschmidt-Clermont PJ, DiFede DL, White I. e-Letter: Amniotic Exosome and Pregnancy. Science Translational Medicine 11, Issue 492, eaav8521 (doi: 10.1126/scitranslmed.aav8521), 2019.

250. Gonzalez MJ, Kweh MF, Biava PM, Olalde J, Toro AP, Goldschmidt-Clermont PJ, White IA. Evaluation of exosome derivatives as bio-informational reprogramming therapy for cancer. J Transl Med 19:103 Doi: 10.1186/s12967-021-02768-8; 2021.

251. Goldschmidt-Clermont PJ, Hubinont C, Goldschmidt AJP, DiFede DL, White IA. Pregnancy a Unique Case of Heterochronic Parabiosis and Peripartum Cardiomyopathy. Frontiers Biosciences, 26(9):666-672. doi: 10.52586/4975. 2021.

252. Goldschmidt-Clermont PJ, Goldschmidt AJP. Rivalry between humans & coronavirus: unanticipated impact of Omicron. J Women Health Care Issues 5(2) Doi: 10.31579/2642-9756/109. 2022

253. Goldschmidt-Clermont PJ, Khan A, Guest JD, Jimsheleishvili G, Graham P, Brooks A, Silvera R, Goldschmidt AJP, Pearse DD, Dietrich D, Brown R, Levi AD. A novel therapy for ALS: allogeneic Schwann cell extracellular vesicles. medRxiv preprint doi: https://doi.org/10.1101/2023.01.18.23284378. 2023

254. Goldschmidt-Clermont PJ, Khan A, Jimsheleishvili G, Graham P, Brooks A, Silvera R, Goldschmidt AJP, Pearse DD, Dietrich D, Brown R, Levi AD, Guest JD. Treating amyotrophic lateral sclerosis with allogeneic Schwann cell-derived exosomal vesicles: a case report. Neural Regeneration Research ():10.4103/NRR.NRR-D-23-01815,. | DOI: 10.4103/NRR.NRR-D-23-01815. 2024

OTHER WORKS, PUBLICATIONS AND ABSTRACTS:

1. Goldschmidt PJ. Disclosure of outside income. Arch Intern Med. 2011 Nov 14; 171(20):1862.

2. Dong C, Goldschmidt-Clermont PJ. Bone sialoprotein and the paradox of angiogenesis versus atherosclerosis. Circ Res. 2000; 86:827-828. Editorial.

3. Seshiah PN, Goldschmidt-Clermont PJ. Detection of the threatening atherosclerotic plaque: Technological advancement and opportunities. Am Heart J. 2000. Editorial.

4. Goldschmidt-Clermont PJ, Cooke GE, Eaton GM, Binkley PF. PIA2, a variant of GPIIIa implicated in coronary thromboembolic complications. J Am Coll Cardio. 2000; 36(1): 90-93. Editorial.

5. Kandzari DE, Goldschmidt-Clermont PJ. Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors. J Am Coll Cardiol. 2001; 38: 1028-1032. Editorial.

6. Taylor DA, Hruban R, Rodriquez ER, Goldschmidt-Clermont PJ. Cardiac chimerism as a mechanism for self-repair: Does it happen and if so to what degree? Circulation. 2002; 106 (1): 2-4. Invited Editorial.

7. Dong C, Crawford LE, Goldschmidt-Clermont PJ. Endothelial progenitor obsolescence and atherosclerotic inflammation. J Am Coll Cardiol. 2005; 45:1458-1460. Editorial.

8. Goldschmidt PJ. UM-Jackson partnership is healthy, enduring. The Miami Herald. April 9, 2007:A18. Editorial.

9. Goldschmidt PJ. Forge partnerships for growth. The Miami Herald. September 5, 2007:A19. Editorial.

10. Goldschmidt PJ. Is running good for everyone? No. The Miami Herald. December 1, 2007:23A. Editorial.

11. Goldschmidt PJ. We must balance limited resources. Sun-Sentinel. January 8, 2008:13A. Editorial.

12. Goldschmidt-Clermont PJ. Jay and Jeanie Schottenstein Prize in Cardiovascular Science: Predicting Cardiovascular Illnesses for the 21st Century, and the Unpredictable…Antioxidants & Redox Signaling. 2009; 11(3): 1-6. Invited Editorial.

13. Goldschmidt PJ. U.S. funds can help research. The Miami Herald. December 21, 2008: 3L. Editorial.

14. Goldschmidt-Clermont PJ, Armstrong D. Eunice Shriver Had a Big Impact in South Florida. The Miami Herald.com. August 26, 2009. Editorial.

15. Goldschmidt-Clermont P. Consultation: Heart of the Matter. International Innovations. November 2009. Page 34-36.

16. Nemeroff CB, Goldschmidt-Clermont PJ. In the Aftermath of Tragedy: Medical and Psychiatric Consequences. Academic Psychiatry. 2011 Jan.-Feb.; 35(1): 4-7. Commentary.

PROFESSIONAL

NIH STUDY SECTION:

06/17/2002 – 06/18/2002 Experimental Cardiovascular Sciences Study Section

06/16/2003 – 06/17/2003 Experimental Cardiovascular Sciences Study Section

07/01/2003 – 12/31/2003 Experimental Cardiovascular Sciences Study Section

10/17/2003 – 03/08/2006 Atherosclerosis and Inflammation of the Cardiovascular System Study Section

OTHER NIH SERVICE:

11/03/1998 – 11/04/1998 National Heart, Lung, and Blood Institute Special Emphasis Panel

11/21/2000 – 11/21/2000 Center for Scientific Review Special Emphasis Panel

10/11/2002 – 10/11/2002 National Heart, Lung, and Blood Institute Special Emphasis Panel

05/14/2012 – 05/15/2012 National Heart, Lung and Blood Institute – Board of Scientific Counselors Review

FUNDED RESEARCH

7/1/08 – 2/29/2020 R01 CA136387-06. Title:  Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis. Role:  Co-P.I.s: Enrique A. Mesri and Pascal J. Goldschmidt-Clermont; Funding:  $2,286,115.

9/8/10—5/31/15 Individualized Risk Stratification Using the Genomic Contribution; NIH/NHLBI #: 1R01HL102487; Role:  Co-Investigator (3%); P.I. Gary W. Beecham and David M. Seo; Total Direct Cost:  $2,449,847

9/1/08 – 8/31/17 Advance Partnerships for Adaptation, Implementation, and Dissemination (PAID) Award: Scientists and Engineers Expanding Diversity and Success (SEEDS) at the University of Miami. National Science Foundation (NSF); HRD-0820128; Kathryn W. Tosney (P.I.); Total:  $543,441

3/1/07 – 2/29/08 Ryan White Title I Health and Support Services for Persons Living with HIV/AIDS REP#0307; Miami-Dade County; Role:  P.I.; Total Direct Cost: $3,319,786

7/1/04 – 6/30/10 Impact of Aging on Stem Repair in Atherosclerosis; 5R01 AG023073-01A1 Role:  P.I. (10%); Total Direct Cost:  $1,216,654

1/25/04 – 4/1/06 The Genetics of Biobehavioral Risk Factors for CVD; HL36587; Role:  Project 1 – Consultant; Core C

10/1/03 – 3/31/05 Progenitor Cell Based Therapeutic Strategies for Atherosclerosis

2003 Doris Duke Clinical Interfaces Award; Total Direct Cost:  $80,000

9/30/03 – 4/1/06 Angiogenesis and Mechanisms of Exercise Training in PAD. HL075752-01; Role:  Consultant

4/1/03 – 4/1/06 GENECARD: Gene Identification in Early-Onset CAD. HL073389-02; Role: Consultant

9/30/02 – 4/1/06 Mentored Clinical Research Scholar Program; RR17630-03; Role:  Mentor 

9/30/02 – 4/1/06 A Comparative Approach to Genomics of Complex Traits. P01 HL73042/HG02384; Role:  P.I.; Total Direct Cost:  $14 million

8/15/02 – 3/31/07 General Clinical Research Center; NIH# M01 RR16587; Role:  P.I. (5%)

7/1/02 – 6/30/08 Title: Rac, Superoxide and Antioxidants in Hypertension. 5R01 HL71536; Role:  P.I. (15%)

7/1/02 – 6/30/05 Medtronic - Duke Cardiovascular Strategic Alliance to Improve Human Welfare Medusa – Medtronic; Role:  P.I.

4/1/01 – 3/31/04 Title:  Dynamics of Flow-Dependent Arterial Permeability. NIH#: R0-1 HL50442  Role: Co-Investigator (10%); (P.I.: M. Friedman) 

4/1/97 – 3/31/01 Field: Endothelial cell dysfunction, growth factors and vasoactive mediators in accelerated graft arteriosclerosis; Endothelial cell dysfunctional apoptosis in AGA; Sandoz Pharmaceutical; Role:  P.I. (20%)

1/1/97 – 12/31/01 Field: Integrins, polymorphisms, thrombosis and pharmacogenetics. Title: Platelet PLA2: studies on a pro-thrombotic polymorphism. NIH#: R0-1 DK57488; Role:  Co-Investigator (10%); Paul F. Bray (P.I.)

7/1/96 – 6/30/00 Title: Tyrosine kinase signaling pathway in post-ischemic inflammation. American Heart Association Established Investigator Award. AHA#: 0 95002600; Role:  P.I.

6/1/96 – 9/30/00 Field: Organization and regulation of actin cytoskeleton. Title:  Profilin I: an essential protein in cells and animals. (Renewed as HL71536) NIH#:  GM053236; Role:  P.I. (20%)

5/1/96 – 4/30/00 Field: Endothelial cell dysfunction, growth factors and vasoactive mediators in accelerated graft arteriosclerosis; Endothelial cell dysfunctional apoptosis in AGA. Sandoz Pharmaceutical; Role:  P.I. (5%)

1/15/95 – 12/31/99 Field: Cell signaling in post-ischemic inflammation. SCOR-project title: Tyrosine kinase signaling pathway in post-ischemic inflammation. NIH#: P50 HL52315; Role:  P.I. (50%)

9/1/94 – 4/1/06 Field: Systemic Sclerosis:  Molecular mechanisms underlying vascular cell abnormalities and intimal lesion formation in scleroderma. Emphasis: TGF-β and Smads; Scleroderma Research Foundation; Role:  P.I.

ADDITIONAL PAST GRANTS:

1992 -- 1995 Syntex Scholars Program Award; The control of cell motility by receptor tyrosine kinase; Role:  P.I.

1992 – 1994 AHA-Grant-In-Aid; The control of cell shape by receptor tyrosine kinase; Role:  P.I.

1991 – 1993 Clinician Scientist Award; Tyrosine phosphorylation of phospholipase C and cytoskeleton reorganization; Role:  P.I.

EDITORIAL RESPONSIBILITIES

EDITORIAL BOARDS:

Executive Editor, Antioxidants and Redox Signaling

Honorary Editorial Board, Integrated Blood Pressure Control

Honorary Editorial Board, Stem Cells and Cloning: Advances and Applications

Editorial Board, American Heart Journal

Editorial Board, The American Journal of Medicine

Editorial Board, Biomedical Microdevices

Editorial Board, Cardiology

Editorial Board, Clinical and Translational Science

Editorial Board, Journal of Translational Medicine

REVIEWER RESPONSIBILITIES:

American Heart Association: Abstracts for Scientific Sessions, Grant-Reviewer (MD-Affiliates, past) 

American Heart Journal

Annals of Internal Medicine 

Antioxidants & Redox Signaling

Archives of Internal Medicine

Atherosclerosis

Atherosclerosis, Thrombosis and Vascular Biology

Biochemistry

Blood

Cell

Cell Adhesion and Communication

Circulation

Circulation:  Cardiovascular Genetics

Circulation Research 

Diabetologia

Drug Discovery Today: Disease Mechanisms 

European Heart Journal

Hypertension

Journal of the American College of Cardiology 

Journal of the American Medical Association

Journal of Cell Biology 

Journal of Cellular and Molecular Medicine

Journal of Clinical Investigations

Journal of Vascular Research

Katz Awards

Molecular Biology of the Cell

Nature

New England Journal of Medicine 

PLoS Pathogens

Proceedings of the National Academy of Sciences of the United States of America

PROFESSIONAL AND HONORARY ORGANIZATIONS

Alpha Omega Alpha Honor Medical Society (AOA)

American College of Cardiology (ACC)

American College of Physicians (ACP)

American Heart Association

Member, Council on Arteriosclerosis, Thrombosis & Vascular Biology

Member, Council on Basic Cardiovascular Sciences Interdisciplinary Working Group on 

Atherosclerotic Peripheral Vascular Disease

American Medical Association 

American Society of Clinical Investigation (ASCI)

Association of Academic Health Centers International (AAHC)

Member, International Coordinating Committee

Association of American Physicians (AAP)

Association of Professors of Medicine, 

Member, Communications Committee

Association of University Cardiologists

European Academy of Sciences

OTHER PROFESSIONAL ACTIVITIES:

.

Advisory Board Member, Ohio Memorial Hospital

Advisory Board Member, Vaccine and Gene Therapy Institute of Florida (VGTI)

External Advisory Board Member, University of California, Davis Clinical and Translational Science Center

Member, Executive Committee, Health Council of South Florida

Member, International Board of Advisors, University of Milan

Scientific Advisory Committee Member, Jim Moran Heart and 

Vascular Research Institute (JMHVRI), Holy Cross Hospital, Fort Lauderdale, Florida

INVITED LECTURESHIPS AND SPEAKING ENGAGEMENTS

American Health Sciences University and Academic Heath System in Namibia, Africa. MKP South Africa Group, Johannesburg South Africa, May19, 2018

21st Century Medicine, West Virginia University, Distinguished Professor Lecture, Robert C. Byrd Health Sciences Center, April 6, 2017

Of the importance of culture and common purpose: the evolution of Global Health, MHCC, Marrakech Morocco, January 20, 2017

Concept for a novel Health System to serve the West Coast of Africa, MHCC, Marrakech Morocco, November 21, 2016

Evolving care that is relevant, cost-effective and delivers value, The 6th U.S.-China Health Summit, September 3, 2016

Welcoming Remarks, “2015 Annual Society of Neurological Surgeons”, Mandarin Hotel, Miami, Florida, June 7, 2015

Welcoming Remarks, “McKnight Brain Research Foundation/Inter-Institutional Meeting”, Hyatt Regency, Miami, Florida, April 30, 2015

"New Advances in Interventional Cardiology", Women’s Lunch Bunch, Lauderdale Yacht Club, Fort Lauderdale, Florida, April 23, 2015

“Towards Personalized Cancer Medicine”, Miami Winter Symposium, Hyatt Regency, Miami, Florida, January 19, 2015

“Role in International Disaster Preparedness and Response – Lessons Learned and Current Gaps”, Humanitarian Assistance and Disaster Relief (HADR) Conference Expert Consultation Workshop--“Designing the Future of Disaster Preparedness and Responses Using Mobile Technology”, Ronald Reagan Building and International Trade Center, Rotunda Room, Washington, DC, July 23, 2014

“Advances and Treatment of Frailty”, Holy Cross Hospital Auditorium, Ft. Lauderdale, Florida, June 25, 2014

“Of Aging, Inflammation, Frailty, and Stem Cells”, 2014 International Society for Heart Research, Miami Beach Resort, Grande Promenade Room, Miami Beach, Florida, May 14, 2014

“Frailty”, Cardiology Grand Rounds, University of Miami Hospital Seminar Center, Miami, Florida, May 6, 2014

Inaugural Speaker, “Frailty”, Moorings Park Healthy Living, The Center for Healthy Living Theatre, Naples, Florida, July 11, 2013

“The Academic Medical Center under Obamacare – Promises and Problems,” MEDNAX Medical Directors Meeting, Hilton Orlando Bonnet Creek, Orlando, Florida, April 7, 2013

Welcoming Remarks, “Synergy 2012, A Multidisciplinary Approach to Interventional Oncology,” Fontainebleau Miami Beach Hotel, Miami Beach, Florida, November 9, 2012

"Eradication of Coronary Artery Disease: Goal for the 21st Century,” Future of Medicine Summit IV (Panel on Science, Medicine & Community: Latest Advancements in Cardiovascular Disease Research, Treatment & Care), Palm Beach County Convention Center, West Palm Beach, Florida, September 27, 2012

“Get at the Heart of the Matter:  Atherosclerosis Genetics,” Genomic Medicine International Conference, JW Marriott Marquis Hotel, Miami, Florida, May 31, 2012

“Atherosclerosis Inflammation, Genetics and Stem Cell, 2011,” Medical Grand Rounds, JFK Medical Center, Kennedy Conference Rooms 1-3, Atlantis, Florida, March 29, 2012

“Atherosclerosis Inflammation, Genetics and Stem Cell, 2011,” Cardiology Grand Rounds, Leonard M. Miller School of Medicine, University of Miami Hospital Seminar Center A&B, Miami, Florida, March 20, 2012

“Genetics of Cardiac Disease“, Keynote Speaker  -- Vaccine & Gene Therapy Institute Florida (VGTI) Grand Opening, Port St. Lucie, Florida, February 29, 2012

“Biomedical Innovations/Life Science and Technology Park (LSTP)”, RCA Miami and Realtor Association of Miami Conference, Biltmore Hotel – Country Club Ballroom, , Coral Gables, Florida, November 18, 2011

“Future of Cardiovascular Specialties”, Corazon’s Annual Conference, Hard Rock Casino – Grand Ballroom D, Corazon, Inc., Davie, Florida, October 19, 2011

“Personalizing Physical Exercise”, Obesity Symposium, Clinical Research Building – Gordon Center, University of Miami Miller School of Medicine, October 10, 2011

“The Future of Cardiovascular Research”,  International Cardiovascular Conference – M3 2011, Fontainebleau Hotel, Miami Beach, Florida, October 5, 2011

“Medicine as an Ambassador to Peace”, Beckwith visiting Professor, Department of Medicine Grand Rounds, Rhode Island Hospital – George Auditorium,  Warren Alpert Medical School of Brown University, Providence, Rhode Island, May 3, 2011

“What’s New at UHealth:  South Florida’s Most Advanced Medical Care”, Collegetown UM Doctors Lecture Series, Robert and Judi Prokrop Newman Alumni Center, University of Miami Miller School of Medicine, Coral Gables, Florida, April 5, 2011

“Scientific Evidence Behind Minimally Invasive Approach”,  Masters in Repair of Structural Heart Disease (MIRS) Conference, Doral Golf and Resort-Legends Ballroom, Miami, Florida, October 15, 2010

“The Emperor’s New Genes: Tale of Atherosclerosis”, Department of Cardiology Grand Rounds, University of  Miami Hospital Seminar Center – Rooms A & B, University of Miami Miller School of Medicine, Miami, Florida, September 21, 2010

“Historical Background of Robotics in United States”,  International Congress  -- “Advances in Minimally Invasive Treatments (MIT)”, Ritz Carlton South Beach, Miami Beach, Florida, June 28, 2010

“Importance of Service to the Community & the Field of Science”, Commencement Ceremony Speaker, Ransom Everglades High School, Coconut Grove, Florida, May 28, 2010

“The Advantages of Global Collaboration”, Association of Academic Health Centers (AAHC) Inaugural Central and South America Meeting, University of São Paulo Medical School, Sao Paulo, Brazil, May 20 - 21, 2010, May 20, 2010

“Academic Health Centers Models”, Roundtable Discussion, Association of Academic Health Centers (AAHC) Inaugural Central and South America Meeting, University of São Paulo Medical School, Sao Paulo, Brazil, May 20 - 21, 2010, May 20, 2010 

“Atherosclerosis, Stem Cells and Genetics”, Heart and Vascular Institute Grand Rounds, Bunts Auditorium, Cleveland Clinic, Cleveland, Ohio, April 30, 2010 

“Genetics of Cardiovascular Diseases”, Cardiovascular Freshman Lecture, Auditorium 126, Florida Atlantic University, Boca Raton, Florida, April 22, 2010

"Genomics and Cellular Therapy-Implications for Cardiovascular Disease", Holy Cross Cardiovascular Symposium, Holy Cross Hospital, Sister Innocent Conference Center,  Fort Lauderdale, Florida, April 10, 2010 

“The Role of Human Rights in Professional Education”, 18th Annual Florida Ethics: Debates, Decisions, Solutions, Florida Bioethics Network Spring 2010 Conference, Miami Beach Resort and Spa, Miami Beach, Florida, April 9, 2010 

“Rebuilding for Resilience/Haiti Reconstruction”,  International Multidisciplinary Forum -- “Rebuilding for Resilience: How Science and Engineering Can Inform Haiti’s Reconstruction”, The Storer Auditorium, University of Miami, Coral Gables,  Florida, March 22, 2010

"The Challenges of Medical Education in the Current Climate of Healthcare Reform", Annual Meeting of the Southeastern Section of the American Urological Association, Loews Hotel, Miami Beach, Florida, March 11, 2010

“Atherosclerosis, Stem Cells, Genetics”, Department of Medicine Grand Rounds Lecture, Northwestern University, Chicago, Illinois, March 2, 2010

“Cardiovascular Medicine (Where are we Heading?)”, Cardiovascular Congress 2010, Gordon Center for Research in Medical Education,  University of Miami Miller School of Medicine, Miami, Florida, February 26, 2010

“Autonomous Innovations in Healthcare”,  Institute of Medicine and the National Academy of Engineering Joint Regiional Meeting, The Storer Auditorium, University of Miami, Coral Gables,  Florida, February 25, 2010

“Medical Knowledge in the IT Era”, Ralph H. and Ruth F. Gross Biennial Lecture, Louis Calder Memorial Library, University of Miami Miller School of Medicine, Miami, Florida, December 10, 2009

“Role of Mitochondria in the Biology of Reactive Oxygen Species”, MitoClub Seminar, University of Miami Miller School of Medicine, Miami, Florida, December 1, 2009

"Will US providers meet the competition form International Specialty Surgery Providers and their Rapid Advances in Healthcare Delivery Systems", Health Care Globalization Summit, Panel Participation, Miami, Florida, November 12, 2009

“Predicting Cardiovascular Illness in the 21st Century”, Keynote Address, 23rd Annual Meeting of the Florida Chapter of the American College of Cardiology, August 21 – 23, 2009, Lake Buena Vista, Florida, August 22, 2009

“Keeping Innovation Alive in the Brave New World of Health Care Finance and Regulation”, Roundtable Discussion, Thought Leaders Summit, March 12 - 14, 2009, Hollywood, Florida, March 13, 2009

“Cardiology 2020”, Cardiovascular Congress 2009, Miami Beach, Florida, February 19 – 21, 2009, February 20, 2009

“The Role of Genomics in the Prevention of Cardiovascular Disease”, Keynote Speaker, Harvard Medical School and the University of Miami Leonard M. Miller School of Medicine Pri-Med South 2009 Conference and Exhibition, Fort Lauderdale, Florida, February 15, 2009

“The Global Implications of Genomics”, Panel Discussion, University of Miami Global Business Forum, University of Miami, Coral Gables, Florida, January 16, 2009

“Predicting Cardiovascular Illnesses for the 21st Century, and the Unpredictable…”, Keynote Lecture, 2008 Dorothy M. Davis Heart & Lung Research Institute Retreat, The Ohio State University, Columbus, Ohio, October 28, 2008

“Myocardial Infarction, from Unstable Plaque to Progenitor Cells” Cardiology Grand Rounds Lecture, The Ohio State University, Columbus, Ohio, October 27, 2008

“Aligning Multiple Clinical Sites with the Academic Health Center Mission”, Panel Discussion, Association of Academic Health Centers 2008 Annual Meeting, Scottsdale, Arizona, October 16 – 18, 2008, October 18, 2008

“Genes, Stem Cells and CAD”, Transcatheter Cardiovascular Therapeutics Conference, Washington, D.C., October 12 – 17, 2008, October 14, 2008

“Predicting Cardiovascular Illnesses for the 21st Century”, University of Miami/University of Pisa Third Course in Dermacosmetology, Pisa, Italy, September 16, 2008

“Medical Education in the 21st Century”, Society for Education in Anesthesia 2008 Spring Annual Meeting, Miami Beach, Florida, June 6, 2008

"Stem Cell and Atherosclerosis", 14th Annual International Society for Cellular Therapy (ISCT) Meeting, Miami, Florida, May 20, 2008

“Heart Healthy at Any Age,” Women’s Health Day Lecture, University of Miami Hospital, Miami, Florida, May 17, 2008

“Genes, Stem Cells and CAD,” Cardiology Grand Rounds, University of Pittsburgh Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, May 13, 2008

“Perspective on Future of Genomics”, Miami Institute for Human Genomics Genetic Analysis of Complex Human Diseases Course, Miami, Florida, May 5 – 8, 2008, May 7, 2008

“Miami:  A Medical Destination”, Greater Miami Chamber of Commerce, Miami, Florida, May 7, 2008

"Remarks about Regional Medical Campuses from a Dean's Perspective", Association of American Medical Colleges, Group on Regional Medical Campuses Spring Meeting April 9 – 11, 2008, Boca Raton, Florida, April 10, 2008

“Miami-Dade as a Medical Destination”, American College of Cardiology Florida Chapter, 30th Annual Cardiovascular Symposium, February 21 – 24, 2008, Hollywood, Florida, February 22, 2008

“Aging: not just the passage of time”, Veterans’ Administration Geriatrics and Gerontology Grand Rounds Miami, Florida, February 21, 2008

"Vaccine, the best human prevention yet", Neonatology 2007: Association of Administrators in Academic Pediatrics (AAAP), Miami, Florida, November 8, 2007

"Cardiac Genomics", South Miami Heart Center 2007 Comprehensive Cardiovascular Conference, Coral Gables, Florida, October 19, 2007

"At the leading edge of medicine: from genomic prevention to robotic surgical solutions", Fundamentals of Translational Science, Miami, Florida, September 21, 2007

“Genomics of Cardiovascular Disease”, Baptist Hospital South Florida Cardiovascular Conference, Miami, Florida, September 20, 2007

"Burden of Atherothrombosis: Mechanisms and Pathology on Vascular Cell Morphology and Repair", AHA-4th Symposium of the Burden of Therosclerotic Disease: Diagnosis and Therapy, New York, New York, June 9, 2007

"Effects of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes", Cardiovascular Disease Forum Journal Club, Miami, Florida, June 6, 2007

“Synecor: A New Paradigm for Rapid Commercialization of Medical Terminology", Miami, Florida, May 8, 2007

"Arterial Disease and Repair", InterAmerican Society of Hypertension and Consortium for SE Hypertension Control, Miami, Florida, May 5, 2007

“The Genomics of Atherosclerosis and CAD”, Preventive Cardiovascular Therapeutics Symposium, Coral Gables, Florida, April 20, 2007

“Aging and the Heart”, Biology of Aging Seminar, Miami, Florida, March 20, 2007

“The Genomics of Atherosclerosis”, Ochsner Clinic Foundation and Health Systems Basic Science in Clinical Medicine Lecture Series, Medical Grand Rounds, New Orleans, Louisiana, March 12 - 13, 2007

“Myocardial Infarction: From ST-Elevation to Genomics",15th Annual Miriam Lemberg Visiting Professorship in Cardiovascular Disease Lecture, Department of Medicine Grand Rounds,  Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, March 7, 2007

"Generation G-for Genome-and the Legacy of the Boomers", Rodney Howell Lecture. Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, February 23, 2007

"Endothelial Cell Therapy and Aging”, Veterans’ Affairs Medical Center Geriatric Institute Grand Rounds, Miami, Florida, February 15, 2007

"How to have your steak and live to enjoy it”, 5th Annual Miami International Revascularization Summit, Miami, Florida, February 9, 2007

"New Jenner-ation”, 2007 Biotech Symposium, Miami, Florida, January 28, 2007

“How to Have Your Steak and Live to Enjoy It, Too”, 42nd Annual Postgraduate Course of Internal Medicine Update 2007, Miami, Florida, January 23, 2007

“Aging of endothelial precursors”, National Institutes of Health Angiogenesis in the Nervous System Workshop, Bethesda, Maryland,  December 12, 2006

“Checkmate!” IBM and Scripps Telephone Conference, November 17, 2006

“How to Have Your Steak and Live to Enjoy It, Too”, Nutrition, Fitness and Global Health Conference, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, November 11, 2006

“Diversity in Medicine”, Southeastern American Medical Student Association (AMSA), Leonard Miller School of Medicine, University of Miami, Miami, Florida, November 10, 2006

“Educating Doctors: The International Era”, Medical Grand Rounds, Leonard Miller School of Medicine, University of Miami, Miami, Florida, October 3, 2006

“How to Enjoy your Steak and Eat It, Too”, Medical Grand Rounds, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, June 30, 2006

“Of Aging, Cellular Repair and Atherosclerosis”, Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota, November 29, 2005

“Session-Restenosis, Atherosclerosis, and Angiogenesis-Is There a Link? Stem Cells and Plaque Growth”, American Heart Association Scientific Sessions, Dallas, Texas, November 13, 2005

“Anemia, Cytokines, and Bone Marrow Responses on Cardiovascular Function”, Amgen, Anemia: A Modifiable Risk Factor for Heart Disease, American Heart Association Scientific Sessions, Dallas, Texas, November 12, 2005

“Genome Expressions Profiling”, Session-From Genome to Phenome: The Translational Biology of Cardiovascular Disease, American Heart Association Scientific Sessions, Dallas, Texas, November 12, 2005

“Designer Genes: From Plaque to Attack-Introducing novel Genomic and proteomic markers of atherosclerosis versus atherothrombosis”, AEHA, SHAPE Task Force Symposium, American Heart Association Scientific Sessions, Dallas, Texas, November 12, 2005

“Arterial Repair, Atherosclerosis, Bone Marrow Problems”, 3rd Annual Nathan W. Shock Aging Symposium, Stem Cells: Regenerative Medicine?, Towson, Maryland, September 30, 2005

“Aging, Stem Cells and Coronary Artery Disease”, International Heart Forum Beijing 2005, Beijing, China, September 16, 2005

“Failure of Arterial Repair with Aging Leads to Atherosclerosis”, Boston Medical Center, Boston, Massachusetts, September 13, 2005

“Arterial Homeostasis, Inflammation, and Erythropoietic Growth Factors”, Amgen, Anemia: A Modifiable Risk Factor for Heart Disease” Roundtable, Boston, Massachusetts, July 15, 2005

“Cell Therapy Solutions for Arterial Disorders”, Cardiology Grand Rounds, University of California, San Francisco, California, May 18, 2005

“Cell Therapy Solutions for Arterial Disorders”, American Society of Hypertension, San Francisco, California, May 16, 2005

“Progenitor Cells in Cardiovascular Disease”, Society of Vascular Surgery, Washington, D.C., April 8, 2005

“Arterial Inflammation and Repair in Atherosclerosis and CAD”, New York University Medical Center, New York, New York, March 22, 2005

“Cell-Based Therapy: Myth or Reality”, American College of Cardiology Scientific Sessions, Orlando, Florida, March 8, 2005

“Functional Genomics”, American Society of Hypertension, Inc., Naples, Florida, January 15, 2005

“The Era of Bone Marrow Derived Repair – Competent Cells for Atherosclerosis”, NIA Stem Cells and Aging Meeting, Bethesda, Maryland, November 10, 2004

“Gene Expression Studies of Atherosclerosis”, American Heart Association Scientific Sessions, New Orleans, Louisiana, November 7, 2004

“Cardiovascular Genetics, Genomics, and Proteomics”, Transcatheter Cardiovascular Therapeutics, Washington, D.C., September 27, 2004

“The Era of Cell Therapy for Cardiovascular Disease”, SingHealth Grand Rounds, Singapore National Heart Centre, Singapore, July 22, 2004

“Vascular Progenitor Cells and Atherosclerosis”, Richard V. Ebert Visiting Professor Medicine Grand Rounds, University of Arkansas for Medical Sciences, Little Rock, Arkansas, July 15, 2004

“Vascular Progenitor Cells and Atherosclerosis”, Medical Center Medicine Grand Rounds 

 New York, New York, July 7, 2004

“Defining the PCI Patient Who Benefits from GP Iib/IIIa Inhibition”, 2004 Report Card on Interventional Coronary Management, Chicago, Illinois, June 12, 2004

“Vascular Progenitor Cells and Atherosclerosis”, Tulane-LSU Medicine Grand Rounds, Tulane University Health Science Center, New Orleans, Louisiana, June 2, 2004

“Current Controversies in Acute Coronary Syndromes”, Cardiology Grand Rounds, Case Western Reserve University, Cleveland, Ohio, May 13, 2004

“Novel Clues on the Aging Risk in Atherosclerosis and ACS”, The Frank N. Wilson Visiting Professor, Cardiology Grand Rounds, University of Michigan Health System, Ann Arbor, Michigan, May 11, 2004

“Atherosclerosis:  From Genomics to Clinic”, Cardiology Grand Rounds, University of Rochester Med Center, Rochester, New York, April 27-28, 2004

“From Bench to Bedside to Boardroom”, “Bone Marrow Derived Pluripotential Cells in Atherosclerosis”, Society of Vascular Surgery Translational Vascular Research, Bethesda, Maryland, April 1, 2004

“Rac1 Regulation of the Cardiovascular System”, 2nd Annual International Conference on NAD (P) H Oxidases (NoxII), Pine Mt., Georgia, March 30 - 31, 2004

“Progenitor Cell Based Therapeutic Strategies for Atherosclerosis”, Doris Duke Clinical Scientist Meeting, Cold Spring Harbor, New York, March 20 - 21, 2004

103.“Platelet Phenotyping and Quality Control Issues”, Johns Hopkins GeneSTAR Meeting, Baltimore, Maryland, March 19, 2004

“Genomics of Cardiovascular Disease”, Eighth Duke Advanced Interventional Cardiology Symposium, Vail, Colorado, January 15-18, 2004

“Bench: Stem Cell Plascity: Are Myogenesis and Angiogenesis Possible?”, “The Aging Vasculature – Cellular Senescence and Atherogenesis”, NHLBI, SCCOR Vascular Diseases in Research Priority Panel, Bethesda, Maryland, December 10-11, 2003

“Going Nano:  To The Vessel and Beyond”, Session Moderator, American Heart Association Meetings, Orlando, Florida, November 9-10, 2003

“New Clues to Cardiovascular Aging”, Johns Hopkins Cardiology Update – 2003, Captiva Island, Florida, October 10, 2003

“On the Memory of Chronic Illness:  The Case for Atherosclerosis”, First Annual Shupar Naimi Lecture in Cardiology, Tufts New England Medical Center, Boston, Massachusetts, September 30, 2003

“Diagnosis and Therapeutic Approaches to ASCVD in the Genomics Era”, “A Primer of Genetics and Proteomics for the Cardiologist”, “Theory Behind Stem Cells and Cardiovascular Repair”.  Discussant, “How and When Will Genetic Profiling Impact Patient Care?”, “When and Which Gene Therapies Will Become Mainstream?” Transcatheter Cardiovascular Therapeutics Meeting, Washington, D.C., September 15, 2003

Co-Chair, Genetics of Cardiovascular Disease Roundtable, Pentagon City, Virginia, September 12-13, 2003

“Understanding the Healing Artery:  From Thrombosis to Lesion Passivation”, Experts on the Evidence:  Prevention and Management of Thrombus in Acute Coronary Syndrome, European Society of Cardiology meeting, Vienna, Austria, September 2, 2003

“Genetics of Coronary Artery Disease” and “Controversies in Cardiology: Detection of Unstable Plaque: What is Best Technique?” The Simon Dack Visiting Professorship, Mt. Sinai Medical Center, New York, New York, June 23, 2003

113.“Translation of Scientific Discoveries on Atherosclerosis into Clinically Relevant Strategies”, Cardiology Grand Rounds, University of Virginia, Charlottesville, Virginia, December 3, 2002

“Basic Mechanisms Underlying Plaque Stability”, American Heart Association Meeting, Chicago, Illinois, November 16, 2002

“The Future of Cardiology”, Corazon Annual Conference, Naples, Florida, October 2, 2002

“Inflammation in PCI”, TCT Symposium, Sept. 25, 2002, “Diagnosis and Therapeutic Approaches to ASCVD in the Genomics Era”, Washington, D.C., September 26, 2002

“Etiology of Atherosclerosis: A Genomic Look”, Intervention 2002, Atlanta, Georgia, September 6, 2002

“Current Understanding of the Pathophysiology of Arterial Thrombosis”, European Society of Cardiology, Berlin, Germany, September 3, 2002

“GPIIIb/IIIa Inhibition and a Drug Eluting Stent”, European Society of Cardiology”, Berlin, Germany, September 1, 2002

“ACC/AHA Guideline Updates 2002”, Takoma Park, Maryland, August 23, 2002

“Beyond the Platelets: Plaque Stabilization-Survival Mechanisms of Abciximab”, Bethesda, Maryland, August 20, 2002

“Implications of Human Genoma in Cardiovascular Disease”, X Simposio International de Cardiopatia Isquemica, Bilbao, Spain, May 22-24, 2002

“Endothelial Function in Vascular Disease”, 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, American Heart Association, Honolulu, Hawaii, April 26, 2002

“Atherosclerosis and Genetics”, Medicine Grand Rounds, Union Memorial Hospital, Baltimore, Maryland, April 25, 2002

“Genomics to Genetics – A Different Approach to Atherosclerosis”, Medicine Grand Rounds, Louisiana State University Medical Center, Shreveport, Louisiana, March 26, 2002

Merck Platelets and Cardiovascular Treatments Symposium, 51st Annual ACC Scientific Sessions, “Pride, Esprit”, Atlanta, Georgia, March 17, 2002

“Human Genetic Affect on Coronary Artery Disease”, 12th Annual Cardiology Symposium, Halifax Regional Hospital, South Boston, Virginia, March 5, 2002

“Progress in Atherosclerosis and CAD: Genomics and Proteomics”, Cardiology Grand Rounds, Baylor College of Medicine, Houston, Texas, February 21, 2002

“Atherosclerosis: The Genomic Era”, 11th Annual Cardiovascular Conference at Beaver Creek, Beaver Creek, Colorado, February 11, 2002

“Searching for the Rosetta Stone of Atherosclerosis”, Cardiology Grand Rounds, Albert Einstein University, Montefiore Medical Center, Bronx, New York, January 29, 2002 

“Antiplatelet Therapy”, Walter Reed Symposium, Womack Army Medical Center, Fayetteville, North Carolina, December 12, 2001

“Platelet Control in Acute Coronary Syndromes, from Therapeutics to Pharmacogenetics”, Cardiology Grand Rounds, Mayo Clinic, Rochester, Minnesota, November 30, 2001

“A New Standard of Care in Acute Coronary Syndromes”, Cardiology Grand Rounds, University of Minnesota Hospital, Minneapolis, Minnesota, November 29, 2001

“Managing Atherothrombosis: Implications of Recent Clinical Trials”, Cardiology Grand Rounds, Gunderson Lutheran Medical Center, La Crosse, Wisconsin, November 28, 2001

Cardiology Conference, University of Miami Hospital, University of Miami School of Medicine, Miami, Florida, 2001

“Pathogenesis of Plaque Instability: A Paradigm Shift in Concept”, Eli Lilly Satellite Symposium, “2001-A Year in Perspective – Spotlight on the Heart during 74th AHA Annual Scientific Sessions, November 11, 2001

“Genetics of Heart Disease: Tailoring Treatment and Prevention”, AMA Reporters Conference, San Francisco, California, October 29, 2001

“Platelet Physiology, Pathology and Genetics in Acute Coronary Syndromes”, Georgia Chapter Annual Scientific ACC Meeting, Savannah, Georgia, October 20, 2001

“Atherosclerosis, From Genetics to Therapeutics”, Cardiology Grand Rounds, The Johns Hopkins Medical Center, Baltimore, Maryland, October 10, 2001 

“Elimination of Coronary Heart Disease by 2050”, Margolis Lecture, Johns Hopkins University, Baltimore, Maryland, September 24, 2001

“Pharmacogenetics”, Intervention 2001, Atlanta, Georgia, September 6, 2001

“Therapeutics for Acute Coronary Syndromes – the Post CURE Era”, Cardiology Grand Rounds, Mt. Sinai Medical Center, Miami, Florida, August 29-30, 2001

“DNA Methylation and Atherosclerosis”, Diet, DNA and Methylation Processes and Health Workshop, National Institute of Health: Bethesda, Maryland, August 7, 2001

“Cardiovascular Disease: Advances in the Treatment and Prevention – The Role of Antiplatelet Agents”, Cardiology Grand Rounds, Tulsa Regional Medical Center, Tulsa, Oklahoma, June 27, 2001

“Platelet Inhibition in Acute Coronary Syndromes: From Bench to Bedside”, Cardiology Grand Rounds, Westchester Medical Center, Valhalla, New York, May 8, 2001

“The Human Genome Project - What Does it Mean to Cardiologists?” 5th Annual Duke-Pinehurst Stent Symposium, Pinehurst, North Carolina, May 5, 2001

Cardiology Grand Rounds, Columbia University, New York, New York, May 2001

“Platelet Glycoprotein (GPIIIa) Variants, Coronary Thromboembolism and Response to Aspirin”, Experimental Biology 2001, Orlando, Florida, April 2, 2001

“Cardiovascular Genomics and Molecular Imaging”, Radiology Grand Rounds, Duke University Medical Center, Durham, North Carolina, March 29, 2001

“Thrombotic Complications and Cardiovascular Disease”, Medicine Conference, Durham Regional Hospital, Durham, North Carolina, March 28, 2001

“Bringing Internet Access and Genomics to Cardiovascular Outcomes Research”, Linking Internet Technology and Duke’s Cardiovascular Databases to Explore Clinical Drug Development Questions, Orlando, Florida, March 19, 2001

“Genetics of Cardiovascular Disease – Impact of Human Genome Project for Cardiovascular Disease”, ACC 50tth Annual Scientific Sessions, Orlando, Florida, March 19, 2001

“Eradication of Coronary Artery Disease by 2050”, Heart Center Grand Rounds, Cleveland Clinic Foundation, Cleveland, Ohio, March 7, 2001

“The Role of Rac and NADPH Oxidase in Hypertension”, Lerner Research Foundation, Cleveland Clinic Foundation, Cleveland, Ohio, March 6, 2001

“An Essay on Longevity, Heart Disease and Your Gene Pool”, Palm Beach, Florida, March 2, 2001

“Inflammation and Thrombosis: From Pathophysiology to Therapy”, 2001 Cardiology Symposium, Raleigh, North Carolina, February 17, 2001

“Platelet Polymorphisms” Tenth Annual Cardiovascular Conference, Beaver Creek, Colorado, February 14, 2001

“Immediate Implications of the Human Genome Project for Cardiology”, Tenth Annual Cardiovascular Conference at Beaver Creek, February 12, 2001

Revolutionizing Ischemic Vascular Disease Management, “Beyond the Platelets: Plaque Stabilization- Survival Mechanisms of Abciximab”, Washington Hospital Center, Washington, D.C., January 31, 2001

“Cardiovascular Disease: Advances in Treatment and Prevention – The Role of Antiplatelet Agents”, Cardiology Grand Rounds, UCSF Medical Center, San Francisco, California, January 24, 2001

“News and Views on the Pathophysiology and Treatment of Acute Coronary Syndromes”, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, January 12, 2001

“Acute Coronary Syndromes: New and Views on Therapies”, Weill Medical College, Cornell University, New York, New York, December 18, 2000

“New Mechanisms of Plaque Destabilization”, Good Samaritan Hospital, Dayton, Ohio, December 13, 2000

“Genetics and Pharmacogenomics of Unstable Coronary Syndromes”, Medicine Grand Rounds, William Beaumont Hospital, Royal Oak, Michigan, December 6, 2000

“Vascular Cell Growth: Basic Mechanisms”, 73rd AHA Scientific Sessions, New Orleans, Louisiana, November 12, 2000

“Platelet Management and Beyond in Acute Coronary Syndromes: A Multifactorial Approach”, Beyond the Platelets: Plaque Stabilization-Survival Mechanisms of Abciximab, New Orleans, Louisiana, November 11, 2000

“New Advances in Antiplatelet Therapy”, Emerging Trends in the Management and Treatment of Atherosclerosis, Chicago, IL, October 21, 2000 and Hot Springs, Virginia, October 27, 2000

“Genetic Mapping to Direct Customized Therapies”, Transcatheter Cardiovascular Therapeutics (TCT) Symposium, Washington, D.C., October 18, 2000

“Thrombosis and Inflammation: Inseparable Processes in Acute Coronary Syndromes”, Cardiology Update 2000 Symposium, Heart and Lung Institute,  The Ohio State University, Columbus, Ohio, October 13, 2000

“Platelet Function” Effects of Estrogen on Thrombosis and Inflammation, Graylyn Conference on Women’s Health, Winston-Salem, North Carolina, October 12, 2000

“Human Genotyping”, Current Concepts in the Diagnosis and Treatment of Adult Heart Disease, Pensacola, Florida, October 6, 2000

“New Treatments with Antiplatelet Agents,” Charlotte, North Carolina, September 30, 2000

“Unmet Needs and Potential Applications: Cardiology”, BioMEMS & Biomedical Nanotechnology World 2000, Columbus, Ohio, September 26, 2000

“Overview of IIB/IIIA Field-Where are we going?” Treatment Strategies for Acute Coronary Syndromes, Pinehurst, North Carolina, September 23, 2000

“Pharmacogenomics of Coronary Thrombosis,” Grand Rounds, University of Michigan,

Ann Arbor, Michigan, September 19, 2000

“Nano-Cardiology: Are we there yet?” Biomedical Engineering Seminar Series, Duke University Medical Center, Durham, North Carolina, September 15, 2000

“New Advances in Molecular-Based Imaging,” Intervention 2000 - Critical Review of Interventional Technology and Interventional Catheterization Skills, Atlanta, Georgia, September 9, 2000

9th Annual Seminar on Molecular Pathology, William Beaumont Hospital, Royal Oak, Michigan, April 14, 2000

“Genetics and Pharmacogenetics of Ischemic Heart Disease”, Grand Rounds, Duke University Medical Center, Durham, North Carolina, January 31, 2000

“Gene Therapy and Heart Disease”, Grand Rounds, Case Western Reserve, Cleveland, Ohio, December 16, 1999

“New Advances in Antiplatelet Therapy”, Grand Rounds, University of Cincinnati, Cincinnati, Ohio, December 7, 1999

“Pathogenesis and Genetics of Atherosclerosis”, Grand Rounds, The Ohio State University Medical Center, Columbus, Ohio, November 4, 1999

“Platelet Inhibition in Acute Coronary Syndromes: From Bench to Bedside”, Grand Rounds, Mt. Carmel Medical Center, Columbus, Ohio, October 26, 1999

First Annual Kyrenia Cardiovascular Center Symposium, New York Hospital Medical Center, Queens, New York, October 19, 1999

“Current Management of Acute Coronary Syndromes”, Grand Rounds, Queen’s Medical Center, Honolulu, Hawaii, September 1, 1999

“New Advances in Antiplatelet Therapy”, Grand Rounds, Wright Patterson Air Force Base, Dayton, Ohio, July 8, 1999

“Molecular Medicine from Gene to Therapy”, Symposium, Cleveland Clinic Foundation, Cleveland, Ohio, June 4, 1999

“The Role of Glycoprotein Iib-IIIa Platelet Inhibitors,” Grand Rounds, Vanderbilt University, Nashville, Tennessee, June 2, 1999

“Molecular Basis of Atherosclerosis,” Grand Rounds, Fawcett Center, Department of Pathology, The Ohio State University, Columbus, Ohio, May 6, 1999

“Genetic and Pharmacogenetic Aspects of Unstable Ischemic Coronary Events”, Grand Rounds, University Hospitals of Cleveland, Cleveland, Ohio, April 29, 1999

“New Advances in Antiplatelet Therapy”, Grand Rounds, Case Western Reserve University, Cleveland, Ohio, April 28, 1999

“Oxidants in mitogenic signaling and cell motility” American Physiological Society Annual Meeting, Washington, D.C., April 19-20, 1999

“Genetic Traits and Pharmacogenomics for Heart Attacks”, Grand Rounds, University of Pennsylvania, Philadelphia, Pennsylvania, April 8, 1999

Grand Rounds, “Genetic Traits and Pharmacogenomics for Heart Attacks,” Boston University, Boston, Massachusetts, April 5-6, 1999

“Platelet Glycoprotein IIIa Polymorphism and Risk for Coronary Thrombosis”, 8th Annual Seminar on Molecular Pathology, William Beaumont Hospital, Royal Oak, Michigan, March 26 - 27, 1999

“Genetic Traits in Pharmacogenomics for Heart Attacks,” Grand Rounds, Kettering Memorial Hospital, Dayton, Ohio, 1999

“Genetic Traits and Pharmacogenomics for Heart Attacks,” Grand Rounds, Wright State University, Dayton, Ohio, February 25, 1999

“Genetic Traits and Pharmacogenomics for Heart Attacks,” Grand Rounds, University of Minnesota, Minneapolis, Minnesota, February 18, 1999

“The Role of Oxidants in Cell Motility and Survival,” Grand Rounds, Department of Pharmacology Medical College of Ohio, Toledo, Ohio, February 17, 1999

“Antiplatelet Therapy: Utilizing Genetic Analysis”, Grand Rounds, Division of Cardiology Medical College of Ohio, Toledo, Ohio, October 15, 1998

“Perfusion: Then and Currently”, Fall 1998 AMSECT Region V Meeting, Columbus, Ohio, October 10, 1998

“Acute Coronary Syndromes and PlA2”, Grand Rounds, University of Pittsburgh, Pittsburgh, Pennsylvania, October 8, 1998

Symposium on Atrial Fibrillation and Antiplatelet Therapy: 1998 and Beyond, Cleveland, Ohio, September 19, 1998

“Prospective on Genetics and Cardiovascular Disease”, Cleveland Clinic Foundation Summit on Cholesterol and Coronary Risk, Cleveland, Ohio, September 3, 1998

“Platelet Glycoproteins,” Speaker, XX Congress of the European Society of Cardiology Vienna, Austria, 1998

“Can Genomic Therapeutics be Applied in Managing Unstable Coronary Syndrome?”, Grand Rounds, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, 1998

“The Advances in Molecular Cardiology: Hope for the Future or Simply Hype?” 11th Annual Cardiology Symposium, Columbus, Ohio, 1998

“Post Translational Signaling”, 21st Annual Conference on Shock, San Antonio, Texas, 1998

“Risk Factors in Coronary Thrombosis”, 28th Annual Postgraduate Medical Seminar, Portsmouth, Ohio, 1997

,“From Genes to Myocardial Infarction: Frontiers of Cardiovascular Science and Medicine in the 21st Century”, Division of Cardiology Spring Conference,  The Ohio State University, Columbus, Ohio, 1997

“Superoxide: Unexpected Mediator of Cell Signaling”, The Cleveland Clinic Foundation, Cleveland, Ohio, 1997

“Genes and Coronary Thrombosis”, XIX Congress of the European Society of Cardiology, Stockholm, Sweden, 1997

“New Genetic Factors in Ischemic Heart Disease”, Grand Rounds, Department of Medicine, Columbia Presbyterian Medical Center, New York, New York, 1997

Keystone Symposia on Molecular and Cellular Biology, Keystone, Colorado, 1996

FASEB-Meeting, Physiology and Pathology of the Splanchnic Circulation, Copper Mountain, Colorado, 1996

“Coronary Heart Disease and Atherosclerosis a Preventable Condition,” St. Mary’s  Medical Center & Good Samaritan Medical Center, Intracoastal Health Systems, Inc., West Palm Beach, Florida, 1996

“Cytoskeleton Dynamics in Health and Disease”, 4th Yale Cell Biology Symposium Peripheral ,Yale University, School of Medicine, New Haven, Connecticut, 1996

“Thrombosis in Myocardial Infarction Trialist Meeting,” Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1995

Lecturer and Chairperson International Meeting on Cytoskeleton and Cancer, Embiez, France, 1995

Lecturer and Session Chairman, Jacques Monod Conferences 1995 Morphogenic Functions of Actin-Associated Proteins, Aussois, France, 1995

Johns Hopkins Medical and Surgical Association Biennial Meeting, Baltimore, Maryland, 1995

Basic Seminar Physiology Department, University of Southwestern Texas, Dallas, Texas, 1995

Cardiology Grand Rounds, University of Massachusetts, Worcester, Massachusetts, 1995

Vascular Biology Seminar, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts, 1995

Cardiology Grand Rounds, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts, 1995

Medical Grand Rounds, Johns Hopkins University School of Medicine, Baltimore, Maryland, 1994

67th Scientific Sessions AHA, American Heart Association, Dallas, Texas, 1994

Gordon Research Conference on Hemostasis, Proctor Academy, Andover, New Hampshire, 1994

43rd Annual Scientific Session American College of Cardiology, Atlanta, Georgia , 1994

Vascular Medicine and Atherosclerosis Unit, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1994

Experimental Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1994

Medical Grand Rounds, Johns Hopkins University, School of Medicine, Baltimore, Maryland, 1994

State of the Art Lecturer, XIVth Congress of the International Society on Thrombosis and Hemostasis, New York, New York, 1993

Cold Spring Harbor Meeting on Cytoskeleton and Cell Function Meeting, Cold Spring Harbor, New York, 1993

Nicholson Lecture, Tuft University, Boston, Massachusetts, 1993 3rd Abercrombie Symposium, Cell Behaviour: Adhesion & Motility, Society for Experimental Biology British Society for Cell Biology, University of Bath, England, 1992

Gordon Research Conference, Motile & Contractile Systems, Plymouth, New Hampshire, 1992

Medical Grand Rounds, Johns Hopkins University, School of Medicine, Baltimore, Maryland, 1992

Actin 1992” Meeting, Albany, New York, 1992

Department of Medicine, University of Michigan, Ann Arbor, Michigan, 1992

Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 1992

Syntex Laboratories, Syntex Scholars Program, Palo Alto, California, 1992

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, 1992

Division of Cardiology, University of Cincinnati, Cincinnati, Ohio, 1992

American Society of Cell Biology Meeting, Boston, Massachusetts, 1991

193rd Annual Meeting of the Medical and Chirurgical Faculty of Maryland, University of Maryland, College Park, Maryland, 1991

Interurban Clinical Club Meeting, Johns Hopkins University School of Medicine,

Baltimore, Maryland, 1991

Finalist, Katz Prize Competition, American Heart Association Meeting, Dallas, Texas, 1990

Research Lecture, National Cancer Institute, Bethesda, Maryland, 1990

Seminaire Extraordinaire, Erasme Academic Hospital, Brussels, Belgium, 1990

Cardiology Division Research Lecture Series, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1990

Joint Meeting of the Societies for Cell Biology and for Biochemistry and Molecular Biology, San Francisco, California, 1989

TEACHING

TEACHING SPECIALIZATION:

Cardiovascular Module (MD), Leonard M. Miller School of Medicine, Rosenstiel Medical Science Building-Fifth Floor Auditorium, Miami, Florida, February 18, 2016

Cardiovascular Module (MD), Leonard M. Miller School of Medicine, Rosenstiel Medical Science Building-Fifth Floor Auditorium, Miami, Florida, February 18, 2015

Cardiovascular Module (MD), Leonard M. Miller School of Medicine, Rosenstiel Medical Science Building-Fourth Floor Auditorium, Miami, Florida, March 12, 2014

Cardiovascular Module (MD), Leonard M. Miller School of Medicine, Rosenstiel Medical Science Building-Fifth Floor Auditorium, Miami, Florida, April 11, 2013

Cardiovascular Module (MD/MPH), Leonard M. Miller School of Medicine, Rosenstiel Medical Science Building-Fourth Floor Auditorium, Miami, Florida, March 14, 2013

Cardiovascular Module (Traditional), “Atherosclerosis Inflammation, Genetics and Stem Cell, 2011,” Leonard M. Miller School of Medicine, Rosenstiel Medical Science Building-Fifth Floor Auditorium, Miami, Florida, April 12, 2012

Cardiovascular Module (MD/MPH), “Genetics of Cardiac Disease”, Leonard M. Miller School of Medicine, Rosenstiel Medical Science Building-Fourth Floor Auditorium, University of Miami, Miami, Florida, March 1, 2012

Cardiovascular Module 2009, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, 

May 29, 2009

Cardiovascular Module, University of Miami/Florida Atlantic University Campus, Boca Raton, Florida, 

May 28, 2009

Interdisciplinary Biomedical Studies Lecture (IBS 603), “Molecular Medicine and Cardiovascular Disease”, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, May 7, 2009

Cardiovascular Module 2008, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, 

May 30, 2008

Cardiovascular Module, “Genetics of Cardiac Disease”, University of Miami/Florida Atlantic University Campus, 

Boca Raton, Florida, May 29, 2008

Interdisciplinary Biomedical Studies Lecture (IBS 603), “Molecular Medicine and Cardiovascular Disease”, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, April 30, 2008

Cardiovascular Module (8 week course), Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, June 2007.

THESIS AND DISSERTATION ADVISING:

Dawn Pedrotty, Defense:  July 16, 2007, Duke University

Qi Ma, Defense:  May 1, 2006, Duke University

Korkut Vata, Defense:  March 21, 2006, Duke University

Bin Yan, Defense:  November 22, 2005, Duke University

Yiting Cao, Defense:  April 28, 2005, Duke University

Tajen Head, Defense: May 14, 2018, University of Miami

SERVICE

UNIVERSITY COMMITTEE AND ADMINISTRATIVE RESPONSIBILITIES:

Johns Hopkins University School of Medicine Director of Cardiology Search, laureate Kenneth Baughman, Baltimore, Maryland

Chair, (appointed by the University President) Senior Vice President and Dean Search, College of Medicine and Public Health Search Committee. Dr. Fred Sanfilippo, laureate (former Chair, Department of Pathology, Johns Hopkins University)

Chair, Selective Investment Committee, The Ohio State University, Columbus, Ohio

Member, University Human Subjects Review Steering Committee, The Ohio State University, Columbus, Ohio

Chair, (appointed by the University President) Task Force for Restructuration of The Ohio State University College of Medicine, Columbus, Ohio

Chair, Search Committee, Director of Cardiothoracic Surgery, Dr. Robert Michler laureate (formerly cardiac surgeon at Columbia University), Ohio State University Heart Center, Columbus, Ohio

Chair, Heart Center Task Force, The Ohio State University, Columbus, Ohio

Duke Center for Genome Ethics, Law and Policy Steering Committee, Duke University, Durham, North Carolina

Duke Center for Genome Ethics, Law and Policy Director, Search Committee, Duke University, Durham, North Carolina

Duke Institute for Genome Sciences and Policy Steering Committee Duke University, Durham, North Carolina

Duke Institute for Genome Sciences and Policy Director, Search Committee, Duke University, Durham, North Carolina

Duke Center for Bioinformatics and Computational Biology Director, Search Committee, Duke University, Durham, North Carolina

Chair, Chief of Gastroenterology Search Committee

Member, Medical Center Leadership Council

Molecular Medicine Coordinators Committee, Duke University Medical Center, Durham, North Carolina

Member, Search Committee for Director of Division of Laboratory Animal Research (DLAR), Duke University Medical Center, Durham, North Carolina

Member, Duke Comprehensive Cancer Center Steering Committee, Durham, North Carolina

Member, Duke University Health System Board of Directors Durham, North Carolina 

Member, Duke University Health System Executive Management Committee Durham, North Carolina 

Member, Duke Executive Committee of the School of Medicine, Durham, North Carolina

Member, Duke Medical Center Executive Committee, Durham, North Carolina

Member, Private Diagnostic Clinic Affairs Committee, Duke University Medical Center, Durham, North Carolina

Member, Private Diagnostic Clinic Administrative Board, Duke University Medical Center, Durham, North Carolina

Member, Joint Liability Steering Committee 

Member, Scientific Advisory Group for The National Children’s Study, Department of Pediatrics, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida

Honorary Member, Jay Weiss Center for Social Medicine and Health Equity, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida

Member, Vascular Biology Institute, University of Miami Leonard M. Miller School of Medicine, Miami, Florida

Member, John P. Hussman Institute for Human Genomics, Leonard M. Miller School of Medicine, Miami, Florida

MENTORING:

Mark I. Furman, former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, currently Lecturer, Harvard Medical School, private practice South Shore Hospital/Division of Cardiovascular Medicine, Weymouth, Massachusetts

Alan W. Heldman, recipient of A.H.A Fellowship Award 1993 and former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, currently Clinical Chief, Division of Cardiology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida

Lawrence E. Crawford, former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, currently Assistant Professor, Division of Cardiology, Duke University Medical Center, Durham, North Carolina

Sanford Gips, former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, currently in private practice, Haddon Heights, New Jersey 

Wendy Post, former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, currently Associate Professor, Johns Hopkins University, Baltimore, Maryland  

Jeffrey Rade, former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, currently Assistant Professor, Johns Hopkins University, Baltimore, Maryland  

Kaikobad Irani, former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, currently Associate Professor, Division of Cardiology, University of Pittsburgh, Pittsburgh, Pennsylvania    

Richard Sohn, former medical student and resident  Johns Hopkins University,  Baltimore, Maryland, currently in private practice, Portland, Oregon

David Kandzari,  former Sarnoff Fellow, Duke University Medical Center, Durham, North Carolina, currently Assistant Consulting Professor, Division of Cardiology, Duke University Medical Center, Durham, North Carolina and Director, Interventional Cardiology Research, Scripps Clinic, La Jolla, California

Ethan Weiss, former MS-IV, Recipient of the Paul Erlich Prize, and resident, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, currently Assistant Professor, Division of Cardiology, University of California, San Francisco

Glen Cooke, former fellow, Division of Cardiology, The Ohio State University, currently Assistant Professor, Division of Cardiology, The Ohio State University, Columbus, Ohio

Nicanor Moldovan, former research scientist, Heart and Lung Institute, The Ohio State University, Columbus, Ohio, currently Assistant Professor, Heart and Lung Institute, The Ohio State University, Columbus, Ohio

Leni Moldovan, Research Scientist, Heart and Lung Institute, The Ohio State University, Columbus, Ohio

Rene Alvarez, former fellow, Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, Associate Professor, Division of Cardiology, University of Pittsburgh and Cardiovascular Institute at University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Professor and Chief of Cardiology at Thomas Jefferson University, Philadelphia, PA.

Chunming Dong, former research scientist, Heart and Lung Institute, The Ohio State University, Columbus, Ohio, currently Professor, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida

Hamdy Hassanain, former research scientist, Heart and Lung Institute, The Ohio State University, Columbus, Ohio, currently Assistant Professor, Heart and Lung Institute and Department of Anesthesiology, The Ohio State University, Columbus, Ohio

Christine Roos, Fellow, Heart and Lung Institute, The Ohio State University, Columbus, Ohio

Anita Kuo Ying, former Sarnoff Fellow/CR Med/Ped program, Duke University Medical Center, Durham, North Carolina, currently fellow, Baylor College of Medicine, Houston, Texas

Tao Wang, former fellow, Heart and Lung Institute, The Ohio State University, Columbus, Ohio, 

 currently Assistant Professor, Pediatrics and Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland 

Dean Boudoulas, former medical student, The Ohio State University, Columbus, Ohio, currently Assistant Professor of Internal Medicine in the Division of Cardiovascular Medicine at The Ohio State University, Columbus, Ohio    

Herve Kovacic, former fellow, Heart and Lung Institute, The Ohio State University, Columbus, Ohio, currently Assistant Professor, Université de la Méditerranée, Marseille, France

Neuza Lopes, former visiting scholar, Heart and Lung Institute, The Ohio State University, Columbus, Ohio, currently Division of Cardiology, Universidade de Sao Paulo, Brazil  

Frederick Rauscher, former medical student and Sarnoff Fellow, Duke University Medical Center, Durham, North Carolina, currently ophthalmology resident, Bascom Palmer Eye Institute, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida

David Gregg, former research post-doc fellow, Duke University Medical Center, Durham, North Carolina, currently Assistant Professor, Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina    

Degen Zhuo, former research associate, Duke University Medical Center, Durham, North Carolina, currently Research Associate, University of Miami Leonard M. Miller School of Medicine, Miami, Florida

Shoukang Zhu, Research Associate, Duke University Medical Center, Durham, North Carolina, currently Research Assistant Professor, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida   

Grace Liang, former research associate, Duke University Medical Center, Durham, North Carolina

Sanjay Vasudevan, former research fellow, Duke University Medical Center, Durham, North Carolina, currently cardiovascular fellow, University of Pittsburgh, Pittsburgh, Pennsylvania   

Balakrishnan  Selvakumar, former graduate student, Division of Cell Biology, Duke University Medical Center former Research Associate, Duke University Medical Center, Durham, North Carolina, currently Research Associate in the Department of Neuroscience at the Johns Hopkins University   

Qi Ma, former graduate student, Division of Cell Biology, Duke University Medical Center, Durham, North Carolina, currently post-doctoral associate, Vascular Biology Institute, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida  

Woohyun Yoon, former graduate student, Division of Cell Biology, Duke University Medical Center, Durham, North Carolina, currently Postdoctoral Associate Staff, Duke University Medical Center, Durham, North Carolina

Huili Wang, former graduate student, Department of Pathology, Duke University Medical Center, currentlyPostdoctoral Trainee, Pathology & Lab Medicine, University of North Carolina – Chapel Hill, North Carolina

Korkut Vata, former graduate student, Department of Pathology, Duke University Medical Center, Durham, North Carolina, currently a freelance negotiator working with Apricum, a green (clean) energy consulting company, based in Germany

David Seo, former fellow, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, currently Associate Professor, Division of Cardiology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida   

Anil Panigrahi, former research associate, Duke University Medical Center, Durham, North Carolina, currently MD/PhD student, University of Pennsylvania, Philadelphia, Pennsylvania  

Ravi Karra, former medical student, Duke University Medical Center, Durham, North Carolina, currently, Research Scientist, Division of Cardiology, Duke University Medical Center, Durham, North Carolina 

Sreekanth Vermulapalli, former medical student, Duke University Medical Center, Durham, North Carolina, currently resident, University of California, San Francisco, California

Arashk Motiei, former medical student, Duke University Medical Center, Durham, North Carolina, currently Assistant Professor of Medicine, Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota

Brian Yue, former resident, Duke University Medical Center, Durham, North Carolina, currently Diagnostic Radiology Fellow, Musculoskeletal Imaging, Duke University School of Medicine, Durham, North Carolina

Ryan Schulteis, former medical student, Duke University Medical Center, Durham, North Carolina, currently student, Medical College of Wisconsin, Madison, Wisconsin

Olujimi Ajijola, former medical student, Duke University Medical Center, Durham, North Carolina, 

currently Fellow in Cardiology, STAR Program (Specialized Training and Research), David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center, Los Angeles, California

Sarah Evans, former medical student, Duke University Medical Center, Durham, North Carolina, currently fellow, Department of Surgery, Duke University Medical Center, Durham, North Carolina

Anuj Malhotra, medical student, Duke University Medical Center, Durham, North Carolina

Enrikas Vainorius, Research Associate, Duke University Medical Center, Durham, North Carolina, currently Clinical Program Manager, ILS, National Institute of Environmental Health Service, National Institutes of Health 

Jason Koontz, fellow, Division of Cardiology, Duke University Medical Center, Durham, North Carolina

Gregory Lam, fellow, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, currently physician, MidOhio Cardiology and Vascular Consultants, Columbus, Ohio 

Ayesha Sarpong, medical student, Duke University Medical Center, Durham, North Carolina, currently radiology fellow, Emory University, Atlanta, Georgia

Albert Sun, former internal medicine resident, Duke University Medical Center, Durham, North Carolina, currently fellow, Division of Cardiology, Duke University Medical Center, Durham, North Carolina

Thomas Povsic, former fellow, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, currently Assistant Professor of Medicine, Duke University Medical Center, Durham, North Carolina

Mythreye Karthikeyan, Research Associate, Duke University Medical Center, Durham, North Carolina, currently Assistant Professor, Duke University Medical Center, North Carolina

Lisa Satterwhite, Senior Research Scientist, Duke University Medical Center, Durham, North Carolina

Xiaohua Song, Research Associate, Duke University Medical Center, Durham, North Carolina, currently Assistant Research Professor, Interdisciplinary Stem Cell Institute, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida

Xialin Liu, former research associate, Duke University Medical Center, Durham, North Carolina, currently Assistant Professor, Zhongshan University, Guangzhou, China

Lina Shehadeh, Assistant Professor of Neurology and Medicine;  Member, Vascular Biology Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, currently Research Assistant Professor, University of Miami Miller School of Medicine, Miami, FL.

Lucas E. Cavallin, M.D.-Ph.D., stellar, award-winning MD-PhD student at the University of Miami Leonard M. Miller School of Medicine, Miami, FL, Lucas is now Dermatology Resident at UPenn in Philadelphia, PA.

Christy Whyte, M.D., Chief-Resident in Emergency Medicine at Emory, 2018 Winner of the Housestaff Organization Professionalism Excellence (HOPE) Award, the highest recognition for an MD-in-Training at Emory. Dr. Whyte was previously an academically gifted Student Athlete at University of Miami (UM). One of the fastest Women in the World, Christy was invited to compete with the Bahamian Olympic Team (she was born Bahamian) at the 2012 Olympic Games in London. But she had a bigger dream, becoming a doctor.  A natural winner, Christy succeeded at all the challenges of becoming a medical student in the U.S., and enrolled at UM with the graduating class of 2015. Once again, she excelled as a  student and got her first choice match for residency in Emergency Medicine at Emory, and today is a graduating Chief-Resident and HOPE Award laureate.

LEADERSHIP RECRUITMENT:

University of Miami

Govindarajan Narayanan, M.D., Founding Chairman of Interventional Radiology Department, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2016)

Allan D. Levi, M.D.-Ph.D., Chairman of Neurological Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2016)

Robert S. Kirsner, M.D.-Ph.D., Chairman, Department of Dermatology and Cutaneous Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2016)

Omaida C. Velazquez, M.D., Chairwoman, Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2015)

Judy Schaechter, M.D., Chairwoman, Department of Pediatrics, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2015)

Neva J. Kirk Sanchez, D.P.T., Chairwoman, Department of Physical Therapy, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2014)

Roy E. Weiss, M.D., Ph.D., Chairman, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2014)

Stephan Zuchner, M.D.-Ph.D., Chairman, Dr. John T. MacDonald Foundation Department of Human Genetics, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2013)

Ira Karmin, M.D., Chairman Department of Obstetrics and Gynecology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2013)

Dipen J. Parekh, M.D. Chairman, Department of Urology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2012)

Stephen D. Nimer, M.D., Director, Sylvester Comprehensive Cancer Center, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2012)

Fred F. Telischi, M.D., Chairman, Department of Otolaryngology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2011)

Glen Barber, Ph.D., Chairman, Department of Cell Biology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2011)

Didier De Canniere, M.D., Professor, DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2010)

Sylvia Daunert, Ph.D., Pharm.D., Chairwoman, Department of Biochemistry and Molecular Biology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2010)

Charles W. Luetje, Ph.D., Chairman of Molecular and Cellular Pharmacology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2010)

Richard Cote, M.D., Chairman, Department of Pathology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2009)

Ruben Quintero, M.D., Director of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2009)

Charles B. Nemeroff, M.D., Chairman, Department of Psychiatry and Behavioral Sciences, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2009)

Eduardo C. Alfonso, M.D., Chairman, Bascom Palmer Eye Institute/Ophthalmology Department, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2009)

Lee D. Kaplan, M.D., Director of UHealth Sports Medicine Institute, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2008)

Alan Pollack, M.D., Chairman, Department of Radiation Oncology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2008)

Sheri Keitz, M.D., Ph.D., Associate Dean for Faculty Diversity and Development, Leonard M. Miller School of Medicine, University of Miami, Chief of Medicine, Miami VAMC (2007)

Marc Lippman, M.D., Chairman of the Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2007)

Bart Chernow, M.D, Vice President for Special Programs and Resource Strategy, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2007)

Frank J. Eismont, M.D., Chairman, Department of Orthopaedic Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2015)

Michele Chulick, Director of Hospital Operations and Associate Vice President University of Miami Health System, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida  (2007)

Diana D. Cardenas, M.D., M.H.A., Chairwoman of the Department of Rehabilitation Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2007)

Mary Moore, Ph.D., Executive Director, Calder Medical Library, Leonard M. Miller School of Medicine, University of Miami (2007)

William O’Neill, M.D., Executive Dean for Clinical Affairs, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2006)

Eli Gilboa, Ph.D., Professor of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2006)

William Donelan, Vice President for Medical Administration and Chief Operating and Strategy Officer, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2006)

Joshua M Hare, M.D., Professor and Chief of Cardiology, Director of Interdisciplinary Stem Cell Institute, Louis Lemberg Professor of Medicine, Assistant Dean of Research, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2006)

Margaret Pericak-Vance, Ph.D., Director, Hussman Institute of Human Genomics, Department of Human Genetics, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2006)

Jeffery Vance, M.D., Ph.D., Division of Human Genetics, Founding Chairman of Department of Human Genetics, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2006)

Ralph L. Sacco, M.D., M.S., Chairman of the Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2006) Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (2009)

Duke University

Paul Noble, M.D., Chief, Division of Pulmonary, Allergy & Critical Care Medicine, Duke University Medical Center, Durham, North Carolina (2005)

Pamela Douglas, M.D., Chief, Division of Cardiology, Duke University Medical Center, Durham, North Carolina (2004)

Nancy Rhodes, M.P.H., Vice Chair, Administration, Finance & Business Strategy, Chief Financial Officer, Department of Medicine, Duke University Medical Center, Durham, North Carolina (2004)

Monica Kraft, M.D., Director, Asthma Center, Duke University Medical Center, Durham, North Carolina (2004)

Geoffrey Ginsburg, M.D., Director, IGSP Center for Genomic Medicine, Duke University Medical Center, Durham, North Carolina (2004)

Anna Mae Diehl, M.D., Chief, Division of Gastroenterology, Duke University Medical Center Durham, North Carolina  (2003)

Nelson Chao, M.D., Chief, Division of Cellular Therapy, Duke University Medical Center, Durham, North Carolina (2003)

Ohio State University

Fred Sanfilippo, M.D., Ph.D., Senior Vice President and Executive Dean for Health Sciences

Dean, College of Medicine and Public Health, CEO, Ohio State University Medical Center, Columbus, Ohio (2000)

Robert Michler, M.D., Chief, Cardiothoracic Surgery, Ohio State University Medical Center, Columbus, Ohio (1997)